1. Introduction {#sec1}
===============

Microarray analyses are a way to study the expression of thousands of genes simultaneously. Microarray analyses are important because they can provide information on genes that are expressed differentially between a control and an experimental sample \[[@B91]\]. However, part of the problem of differential expression methodology is that genes must be expressed in both sample types, the experimental and control samples, for statistical analyses to be possible. Without gene expression data available for a probe set in each sample, the probe set will be discarded by the analysis procedure. The drawback of the differential expression methodology, therefore, is obvious when specific cell types with vastly different identities are being compared \[[@B11]\].

Microarray analyses, however, do provide useful information on the transcripts that are present or absent within samples \[[@B44]\]. Detection call methodology (DCM) reveals the types of transcripts that are present or absent within samples. The DCM is typically used on a single array to answer whether a transcript of a particular gene is present or absent in a sample. Several recent papers have used DCM successfully to understand transcription in various experimental systems \[[@B93]--[@B82]\]. The DCM is useful when cost is an issue because the method can be performed on a single array. More importantly, DCM can be used to compare transcripts between different cell types or of the same cell type at different points during a time course \[[@B11], [@B44], [@B80]\]. None of these examples compared detection calls during a pathological infection. Nonetheless, DCM can provide extremely useful information about the samples under investigation, especially in the analysis of plant pathological systems where a pathogen interacts intimately with a specific cell population within a complex tissue or organ (e.g., root).

The infection of plants by parasitic nematodes is a major agricultural problem that is currently poorly understood (reviewed in \[[@B50]--[@B62]\]). Infection results in damage totaling 157 billion U.S. dollars, annually \[[@B1]\]. Among the most costly is *Heterodera glycines* infection of *Glycine max*, accounting for an estimated \$460 to \$818 million in production losses annually in the U.S. \[[@B113]\]. The *G. max-H. glycines* system is a powerful research tool because both resistant and susceptible reactions can be studied in the same genotype (e.g., *G.*  *max*~\[PI  548402/Peking\]~). Information learned through its genetic and genomic studies can be translated directly to improve resistance in one of the most important global agriculturally relevant plants.

The genetic basis of *G. max* to overcome *H. glycines* infection (an incompatible reaction resulting in resistance) is complex (reviewed in \[[@B18]\]). Several recessive resistance loci (*rhg1*, *rhg2,* and *rhg3*) \[[@B14]\] and dominant resistance loci (*Rhg4*) \[[@B67]\] and (*Rhg5*) \[[@B81]\] have been identified (reviewed in \[[@B18]\]). The understanding of resistance to *H. glycines* has also been aided by other genetic marker technology (e.g., quantitative trait loci (QTL) mapping). Those studies have identified QTLs that map to 17 linkage groups. *G.max*~\[PI  548402/Peking\]~ has nine QTLs that map to different linkage groups (reviewed in \[[@B18]\]). One of those QTLs present in *G.max*~\[PI  548402/Peking\]~ that maps to linkage group G explains more than 50% of resistance to *H. glycines* \[[@B92]\]. It also is responsible for resistance to several different populations of *H. glycines*. The major QTL that is located on linkage group G was identified using the RFLP marker C006V and is designated as *rhg1* \[[@B17]\]. Further studies have shown that molecular marker Satt309 is only 0.4 centiMorgans from *rhg1* \[[@B21]\]. Importantly, much of the resistance that has been bred into elite *G. max* varieties originates from the *G.max*~\[PI  548402/Peking\]~ genotype.

Genomic approaches have also identified transcriptional changes in whole roots during infection \[[@B51]--[@B56]\]. Importantly, a time course microarray analysis was used to investigate the *G. max-H. glycines* interaction \[[@B5]\]. The analysis demonstrated that differential expression of genes was occurring in *G. max* roots undergoing a compatible reaction, a reaction that results in susceptibility. The analysis used time points both prior to and after feeding site selection \[[@B5]\]. Importantly, the differential expression of genes was occurring in *G. max* roots even before the nematodes had selected their feeding sites \[[@B5]\]. Thus, the plant is reacting in important ways to the presence of the nematode before the nematodes have begun to initiate the formation of their feeding sites during a compatible reaction.

The *G. max-H. glycines* interaction is an exceptional model because it is possible to compare gene expression occurring during incompatible (resistant) and compatible reactions. The experiments are possible because even resistant genotypes like *G.max*~\[PI  548402/Peking\]~ undergo infection \[[@B62], [@B55]--[@B60]\]. The comparisons can be made because well-defined incompatible and compatible *H. glycines*races (populations) are available \[[@B62], [@B55], [@B56], [@B58]--[@B75]\]. A time course microarray analysis has examined *H. glycines* infection during both an incompatible and a compatible reaction in whole roots at time points both prior to and after nematodes have established feeding sites \[[@B55]\]. Importantly, those microarray analyses were performed in the same *G. max* genotype (e.g. *G.max*~\[PI  548402/Peking\]~) by using incompatible and compatible populations of *H. glycines*\[[@B55], [@B56]\]. Thus, no possibility existed for *G. max*genotype differences complicating the identification of important gene expression events during those reactions. The analyses have shown that *G. max* behaves differently as it undergoes the incompatible or compatible reaction and these differences in gene expression are detectable as early as 12 hours post infection (hpi) \[[@B55]\]. The 12 hpi time point is a point before the nematode has selected its feeding site. The analyses also showed how expression of *G.max*~\[PI  548402/Peking\]~ genes differs over time between roots undergoing an incompatible or compatible reactions.

The aforementioned investigations were not designed to study gene expression of the syncytium. However, several labs have made histological studies of the infection process. The studies showed that *H. glycines* infest the roots and migrate through the cortex during the early stages of the infestation process. After 24 hpi the nematodes reach the stele where they select and establish their feeding sites \[[@B30]--[@B52], [@B29]\]. Consequently, the feeding site initial (FS~*i*~), a cell that is usually a pericycle cell, fuses with neighboring cells. The process occurs when the cell walls dissolve and the cytoplasm of adjacent cells (e.g., cortex) merges with the feeding site initial. Cell fusion, thus, results in the formation of a syncytium. Syncytial cells continue to develop in compatible roots into sites from which *H. glycines* feed ([Figure 1](#fig1){ref-type="fig"}) \[[@B30]--[@B52]\]. Conversely, syncytial cells of incompatible roots collapse four to five days post infection (dpi) and the nematodes die \[[@B30], [@B32], [@B52]\].

Understanding the localized resistance reaction at the site of infection may also lead to better measures to control *H. glycines* parasitism. The problem, however, has been in isolating these cells to some amount of homogeneity for expression analysis. Hand dissections have been performed to obtain giant cells from galls induced by the root knot nematode (*Meloidogyne incognita*) during a compatible interaction in tomato (*Lycopersicon esculentum*) \[[@B112]\]. The experiments permitted the isolation of cDNA from those cells \[[@B112]\]. However, relatively few of them turned out to be gall specific \[[@B10]\]. The experiments, nonetheless, demonstrated the efficacy of the approach in isolating RNA from those cell types. Unfortunately, it is not possible to use this method to study syncytium formation during *H. glycines* infection.

Laser capture microdissection (LCM) is an alternative means that affords a high degree of precision and accuracy to isolate homogeneous cell populations that are otherwise recalcitrant to their isolation \[[@B45]--[@B8]\]. The method has proven to be especially valuable to study the development of the syncytium during *G. max* infection by *H. glycines* during a compatible and incompatible reaction \[[@B56], [@B60], [@B53], [@B61]\] because *H. glycines*can be used as an in situ physical marker for the syncytium. Microarray analysis studying gene expression of the syncytium has allowed for the identification of genes that exhibit differential expression in these cell types \[[@B56], [@B60]\]. However, it was unclear whether the true diversity of gene expression was being revealed by the differential expression methodology.

In the analysis presented here, DCM was used to compare detection calls made between the different cell types involved in the formation of the syncytium using samples isolated by LCM. The DCM was used to compare how the cell types under investigation (e.g., the syncytium) differed from the cell type(s) from which they originated (e.g., pericycle). Using a comparative analysis aided by customized computer scripts, a broader understanding was obtained of the differences between (1) syncytia and pericycle cells, (2) syncytia undergoing incompatible and compatible reactions, and (3) syncytia at different points of their development during a compatible reaction as they mature into a functional feeding site.

2. Materials and Methods {#sec2}
========================

2.1. Female Index {#sec2.1}
-----------------

The *H.*glycines~\[NL1-RHg\]~ population used in the analyses presented here has been used extensively as race 3 for analyses requiring susceptible reactions in *G. max* genotype Kent (*G.max*~\[Kent\]~) \[[@B51], [@B5], [@B58]--[@B60], [@B53], [@B66]\] and resistant reactions in *G.max*~\[PI  548402/Peking\]~ \[[@B55], [@B56], [@B58], [@B60], [@B4]\]. For a description of the 16 nematode races and the HG-type test, please refer to Niblack et al. \[[@B75]\]. The HG-type test is derived from the original Index of Parasitism test \[[@B40]\]. The determination of the HG-type is based on the performance of the nematode race to infect indicator lines. The indicator lines are *G. max* genotypes (including *G.max*~\[PI  548402/Peking\]~) having varying ability to resist infection by the 16 known races of *H. glycines*. Based on the accepted variation of infection by *H. glycines* on the different indicator lines, an HG-type is given to an unknown sample. The numerous *G. max* genotypes are named by an accepted plant introduction (PI) classification scheme. The indicator lines now used in the HG-type test are *G.max*~\[PI  88788\]~,*G.max*~\[PI  548402/Peking\]~, *G.max*~\[PI  90763\]~, *G.max*~\[Pickett\]~, *G.max*~\[PI  437654\]~ (*G.max*~\[Hartwig\]~), *G.max*~\[PI  89772\]~, *G.max*~\[PI  548316\]~ (*G.max*~\[Cloud\]~), *G.max*~\[PI  209332\]~, and *G.max*~\[PI  438489B\]~. Of note, *G.max*~\[PI  438489B\]~ was added to the HG-type test to allow a more accurate test because it was classified as being resistant to five *H. glycines*races (1, 2, 3, 5, and 14) in the greenhouse \[[@B25]\]. The HG-type test is based off of the presence of an expected number of females, given as a proportion, which will develop on each indicator line. The number is called the female index (FI). The FI is the number of mature females that develop on a test genotype divided by the number of females that develop on a known susceptible genotype (i.e., *G.max*~\[Lee\]~ and/or *G.max*~\[Essex\]~) multiplied by 100. According to the original Index of Parasitism \[[@B40]\] any genotype with a female number less than 10% of the number determined on *G.max*~\[Lee\]~ would be considered resistant (−) and any number above 10% would be susceptible (+). The HG-type test as determined by Niblack et al. \[[@B75]\] has changed the Index of Parasitism test \[[@B40]\] and improved race test \[[@B84]\] to include several other categories. Now, the FI categories for the HG-type test are Highly Resistant, FI: 0%--9%; Resistant, FI: 10%--24%; Moderately Resistant, FI: 25%--39%; Low Resistance, FI: 40%--59%; and No Effective Resistance, FI: \>60%. The HG-type test for *H.glycines*~\[NL1-RHg\]~ was determined independently in the lab of Dr. Terry Niblack (Department of Crop Sciences, University of Illinois) \[[@B54], [@B55]\] during June-July, 2007 using the published methods of Niblack et al. \[[@B75]\]. The performance of *H.glycines*~\[NL1-RHg\]~ on those indicator lines was compared to the susceptible genotypes *G.max*~\[Lee\]~ and *G.max*~\[Essex\]~. An FI of 0 (0%) was found for *H.glycines*~\[NL1-RHg\]~ on *G.max*~\[PI  548402/Peking\]~. Thus, the HG-type test determined that *G.max*~\[PI  548402/Peking\]~ is considered highly resistant to *H.*glycines~\[NL1-RHg\]~. Based on the infectivity of *H.*glycines~\[NL1-RHg\]~ on the indicator lines, the HG-type test also determined that *H.*glycines~\[NL1-RHg\]~ is race 3, as previously published \[[@B51], [@B5], [@B58], [@B53], [@B66], [@B6]\]. *H.*glycines~\[NL1-RHg\]~ (incompatible) is HG-type 7 (*H.*glycines~\[NL1-RHg/HG-type  7\]~). The reaction of *H.*glycines~\[TN8\]~ (HG-type 1.3.6.7 \[race 14\]) (*H.*glycines~\[TN8/HG-type  1.3.6.7\]~) (compatible) on *G.max*~\[PI  548402/Peking\]~ is a susceptible reaction \[[@B74]\].

### 2.1.1. Plant and Nematode Procurement {#sec2.1.1}

The methods have been published previously \[[@B56], [@B60]\]. Briefly, plant and nematode materials were grown at the United States Department of Agriculture, Soybean Genomics and Improvement Laboratory (SGIL). A single *G. max* genotype (*G.max*~\[PI  548402/Peking\]~) was used in the experiments to obtain both incompatible and compatible reactions by the use of two different populations of *H. glycines, H.*glycines~\[NL1-RHg/HG-type  7\]~ and *H.*glycines~\[TN8/HG-type  1.3.6.7\]~. The *H. glycines*populations were maintained in the greenhouse using the moisture replacement system (MRS) \[[@B88]\].

The origin of *H.*glycines~\[TN8/HG-type  1.3.6.7\]~ was by selection of a single-cyst descent on *G.max*~\[PI  90763\]~ \[[@B74]\]. Originally, *H.*glycines~\[TN8/HG-type  1.3.6.7\]~ was maintained on the *G.max*~\[PI  90763\]~ genotype according to Niblack et al. \[[@B74]\]. The *H.*glycines~\[TN8/HG-type  1.3.6.7\]~-infected *G. max* plants were maintained in sterilized field sand medium in 1liter containers. The containers were suspended in a 27°C water bath. Fertilization of *G. max* was done with Peter\'s soluble 20-20-20 nutrients (The Scotts Company; Marysville, OH). Transfer of *H.*glycines~\[TN8/HG-type  1.3.6.7\]~ to a new host was performed routinely on a 30--40 day basis. The *H.*glycines~\[TN8/HG-type  1.3.6.7\]~ population is maintained at SGIL on the susceptible *G.max*~\[Kent\]~. The *H.glycines*~\[NL1-RHg/HG-type  7\]~ population has been maintained on *G.max*~\[Kent\]~ at SGIL. The *H.*glycines~\[NL1-RHg/HG-type  7\]~ population has been used extensively for analyses requiring susceptible reactions in *G.max*~\[Kent\]~ \[[@B51], [@B5], [@B53]\] and resistant reactions in *G.max*~\[PI  548402/Peking\]~ \[[@B55], [@B56], [@B58], [@B60], [@B4]\]. Thus, in side-by-side experiments, *H.*glycines~\[TN8/HG-type  1.3.6.7\]~ and *H.glycines*~\[NL1-RHg/HG-type  7\]~ have always been exposed to the same *G. max* genotypes. The method virtually eliminated variations among the different *G. max* genotypes in influencing the experiments.

Seedlings were grown in sterilized sand in 20 × 20 × 10 cm flats for a period of one week. The plants were gently removed from the sand and rinsed with sterile water. Seedlings were placed on moistened germination paper (Anchor Paper; St. Paul, MN) inside the flats. Mature female nematodes were harvested by massaging the roots in water. Mature nematodes were collected by filtering the solution through nested 850 and 150 *μ*m sieves. Females were further purified by sucrose flotation \[[@B66]\]. The females were crushed gently with a rubber stopper within a 7.5 cm diameter apparatus containing 250 *μ*m sieves. The process released the eggs. The eggs passed through the sieve into a small plastic tray. Debris smaller than the eggs was removed. Debris removal was done by washing the debris in a 25 *μ*m mesh sieve. The eggs were placed in a small plastic tray containing 1 cm of water. The tray was covered with plastic wrap and subsequently placed on a rotary shaker at 25 rpm. After 3 days, the second-stage juvenile nematodes (J2s) were separated from the unhatched eggs. Separation was done by passing them through a 41 *μ*m mesh cloth. The J2s were concentrated by centrifugation in an IEC clinical centrifuge for 30 seconds at 1720 rpm to 5,000 J2/mL. The nematodes were used to infest the roots. There were 2 mL of nematode-containing solution added directly on the roots for a final concentration of 2,000 J2/root. The control mock-infested replicates received the same amount of water. The roots were covered with a moistened sheet of germination paper. The plants were placed in a 45 × 50 × 20 cm plastic tray with a one cm of water in the bottom to add humidity. A semitransparent bag was then wrapped around the tray. The trays were then placed under fluorescent lights of 16/8 hour light/dark photoperiod. Light intensities were identical for all experiments. Infested roots were grown for three or 8 dpi. The mock-infested control samples and susceptible and resistant reactions were washed. The process removed the extraneous nematodes that had not yet penetrated the root, preventing additional nematodes from entering the root. The process ensured that tissue that was the most highly infested with nematodes was obtained. The process was then repeated, providing two independent sets of samples. Seven independent replicates were pooled to obtain each replicate for each sample type in the analysis. Thus, there are a total of 14 replicates used in the analysis. At least 50 serially sectioned syncytia were used for each of the 7 replicates. Materials for histological observation to confirm incompatible and compatible reactions were derived from these samples (see below).

### 2.1.2. Histology {#sec2.1.2}

Histological tissue processing was according to Klink et al. \[[@B56], [@B60], [@B53]\]. Briefly, tissue was fixed in Farmer\'s solution (FS) composed of 75% ethanol and 25% acetic acid v/v \[[@B53], [@B89]\]. Some replicate samples of roots used for immunohistochemical analyses were killed and fixed in 3.7% w/v paraformaldehyde (PFA) buffered with PEMP buffer (100 *μ*M Pipes, 1 *μ*M EGTA, 1 *μ*M MgCl~2~, and 4% w/v polyethylene glycol MW 8000, pH 6.8) \[[@B53], [@B98]\]. *G. max* root tissue was harvested and cut into 0.5 cm pieces. Those pieces were vacuum infiltrated with either FS or PFA at room temperature for one hour (h). Fresh fixative (FS or PFA) was then added to their respective samples. Tissue was subjected to an incubation step of 12 hours at 4°C. PFA fixed tissue was then dehydrated through 10% (v/v), 25% (v/v), 50% (v/v), 75% (v/v) ethanol : water. The remaining procedure was done identically as for FS processed tissue. Fixative was removed from the roots. Dehydration of FS-fixed tissue proceeded through a graded series of 75% (v/v), 85% (v/v), 100% (v/v), 100% (v/v) ethanol : water, 30 minutes each. Ethanol was replaced with 1 : 1 (v/v) xylene : ethanol for 30 minutes. Subsequently, three, 100% xylene incubations (30 minutes each) were done. Xylene was replaced by paraffin. The processing was done slowly by placing the specimens into a 58°C oven. The roots were infiltrated sequentially in 3 : 1 (v/v), 1 : 1 (v/v), 1 :  3 (v/v) xylene : Paraplast+ tissue embedding medium (Tyco Healthcare Group LP; Mansfield, MA) in each step for three hours. Tissue was cast and subsequently mounted for sectioning. Serial sections of roots were made on an American Optical 820 microtome (American Optical Co.; Buffalo, NY) at a section thickness of 10 *μ*m. Sections were stained in Safranin O (Fischer Scientific) in 50% (v/v) ETOH : water and counter-stained in Fast Green FCF (Fisher Scientific). The tissue was permanently mounted in Permount (Fisher Scientific).

2.2. LCM {#sec2.2}
--------

Slides were prepared according to Klink et al. \[[@B56]\]. MembraneSlides (Leica, Germany; Cat\# 11505158) were placed on a slide warmer set at 40°C. DEPC-treated RNAse-free water (\~0.5--1 mL) was placed onto the slide and allowed to warm. The tissues used for these analyses were obtained from the same tissue used in whole-root microarray experiments \[[@B56]\]. Serial sections (10 *μ*m) from control mock-inoculated roots and roots undergoing incompatible (3 dpi) and compatible (3 and 8 dpi) reactions were prepared according to Klink et al. \[[@B56], [@B60], [@B53]\]. Serial sections for the independent sample types were placed directly onto the pool of DEPC-treated water. DEPC-treated water was blotted off with a sterile KimWipe after the serial sections were adequately spread. Tissue was allowed to warm on the slide warmer for an additional hour to promote tissue binding to the slide surface. Slides were deparaffinized for five minutes in xylene. The processing was followed by a two-minute incubation in 1 : 1 (v/v) xylene : ETOH. That was followed subsequently with two one-minute incubations in ETOH. Slides were then dried on the lab bench on filter paper covered with KimWipes. The slides were used immediately for LCM after the drying step was done. LCM was performed on a Leica ASLMD microscope (Leica). Microdissection cutting parameters were determined empirically for each session by examining how amenable the tissue was to LCM. However, cutting parameters for dissections performed on the 40× objective were approximately power, 55--85; speed, 2--4; specimen balance, 1--3; and offset, 40. Similar quantities of cells were obtained for each sample type for the analyses.

Tissue was collected in OptiCaps (Leica Cat. number 11505169) and subsequently washed to the bottom of the OptiCap PCR tube. The process was done by micropipetting 20 *μ*L of XB buffer (Arcturus) onto the microdissected tissue. The cap was spun for five minutes at 500 rpm to pellet the tissue into the bottom of the Opticap. LCM tissue was ground with a micropestle. The process was done in 40 *μ*L RNA extraction buffer (Arcturus). The RNA was extracted and subsequently processed using the PicoPure RNA Isolation Kit (Arcturus). The process was done according to the manufacturer\'s instructions. A DNAse treatment was added, just before the second column wash, using DNAfree (Ambion; Austin, TX). RNA quality and yield were determined. The processing was done using the RNA 6000 Pico Assay (Agilent Technologies; Palo Alto, CA) using the Agilent 2100 Bioanalyzer according to the manufacturer\'s instructions. RNA amplification of LCM samples was performed with the GeneChip Two-Cycle cDNA Synthesis Kit (Affymetrix; Santa Clara, CA: Cat. number 900432). Probe preparation and hybridizations were performed according to Affymetrix guidelines at the Laboratory of Molecular Technology, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21701, USA.

2.3. Microarray Analyses and G. max Probe Set Annotations {#sec2.3}
---------------------------------------------------------

The GeneChip Soybean Genome Array (Affymetrix; Cat. number 900526) containing 37,744 *G. max* transcripts (35,611 transcripts) was used for the microarray analyses. Details of the GeneChip soybean genome array can be obtained (<http://www.affymetrix.com/index.affx>). Annotations were made by comparison to the *Arabidopsis thaliana*gene ontology (GO) database \[[@B102]\] based on their best match obtained by BLAST searches \[[@B7]\]. They were updated (2009).

All microarray hybridizations were performed at the Laboratory of Molecular Technology, SAIC-Frederick, National Cancer Institute at Frederick, Frederick, MD 21701, USA. Local normalization was used. The presence or absence of a particular probe set\'s (gene\'s) transcript on a single array was determined using the Bioconductor implementation of the standard Affymetrix DCM. In summary, the DCM consists of four steps: (1) removal of saturated probes, (2) calculation of discrimination scores, (3) *P*-value calculation using the Wilcoxon\'s rank test, and (4) making the detection (present/marginal/absent). Ultimately, the algorithm determines if the presence of a probe set\'s transcript is provably different from zero (present (P)), uncertain (marginal (M)), or not provably different from zero (absent (A)). Details of the standard Affymetrix DCM can be found in their *Statistical Algorithms Description Document* (<http://www.affymetrix.com/support/technical/whitepapers/sadd_whitepaper.pdf>.). For a particular condition (e.g., 3 dpi syncytia during the incompatible response), a probe set was considered present only if it was present on both replicate microarrays corresponding to that condition. Otherwise, it was considered to be absent. All original data sets, the normalized data sets, statistics, and data supplemental to each table and figure are available at the MAIME compliant \[<http://bioinformatics.towson.edu/SGMD3>\] \[[@B3]\].

3. Results {#sec3}
==========

3.1. Histological Analysis of Incompatible and Compatible Responses in the Whole Root {#sec3.1}
-------------------------------------------------------------------------------------

Morphological and anatomical details of compatible and incompatible disease responses by *G. max* to *H. glycines* infection have been published previously \[[@B30]--[@B83], [@B29], [@B31]--[@B48]\]. Infection during the first 8 dpi ([Figure 2](#fig2){ref-type="fig"}) was focused on for this analysis because syncytial cells complete the incompatible reaction by 8 dpi under the experimental conditions in *G.max*~\[PI  548402/Peking\]~. During a compatible reaction, nematodes have selected and are establishing feeding sites by 3 dpi ([Figure 2(a)](#fig2){ref-type="fig"}) that are continuing to develop by 8 dpi ([Figure 2(b)](#fig2){ref-type="fig"}). During an incompatible reaction, nematodes have also selected and are establishing feeding sites at 3 dpi ([Figure 2(c)](#fig2){ref-type="fig"}). However, during an incompatible reaction, syncytial cells collapse by 8 dpi ([Figure 2(d)](#fig2){ref-type="fig"}). Syncytial cells ([Figure 3(a)](#fig3){ref-type="fig"}) for the various analyses were collected by LCM ([Figure 3(b)](#fig3){ref-type="fig"}).

3.2. The Use of Detection Calls to Identify Genes Present in Syncytium Samples {#sec3.2}
------------------------------------------------------------------------------

The DCM was used to make a comparative analysis of the probe sets measuring the presence of a transcript (present transcript) within LCM-derived cell samples. The analyses would allow (1) the determination of the total number of present transcripts, (2) the determination of the numbers of present transcripts within a sample, and (3) a comparison of the present transcripts between the different sample types while estimating the differences between those samples (4) the identification of whether transcripts that are common between the two sample types under comparison had been identified in a prior differential expression analysis \[[@B56]\]. Only probe sets that measured detection on both arrays for a particular sample type ([Figure 4](#fig4){ref-type="fig"}) were evaluated further (see below).

While detection calls are generally used for single array analyses, the DCM presented here used two arrays for each sample type in a comparison. Thus, for a particular comparison between cell types, four arrays were taken into consideration. Detection calls were analyzed for each of the two arrays for each sample type (e.g., pericycle). Detection calls were made for each of the two arrays independently to determine if the probe sets were consistently measuring present or absent for a particular sample type. For example, the probe set had to obtain a like measurement (e.g., present/present; absent/absent) for each of the two arrays for each sample type to be considered for subsequent analyses ([Figure 4](#fig4){ref-type="fig"}). The arrays that measured present on both arrays within a sample type are considered present. The arrays that measured absent on both arrays within a sample type are considered absent ([Figure 4](#fig4){ref-type="fig"}). The probe sets that failed to produce like measurements (e.g., any combination of present/absent; present/marginal for the two arrays) and those that measured marginal amounts of a transcript for a particular probe set on each of the two arrays (e.g., marginal/marginal) were excluded from the analysis ([Figure 4](#fig4){ref-type="fig"}). The resulting probe sets used in the subsequent analyses were measuring present/present detection calls for each of the two arrays for a particular sample type (e.g., 3 dpi incompatible syncytia).

Comparisons were made between the different sample types (e.g., 3 dpi incompatible syncytia versus pericycle). In those comparisons, four arrays would be compared ([Figure 5](#fig5){ref-type="fig"}). Probe sets that measured detectable amounts of a transcript on the four arrays under comparison were considered common and present between two sample types (e.g., pericycle and 3 dpi incompatible syncytia-common). The probe sets measuring absent on the four arrays (common and absent), although potentially interesting, were not taken into consideration in this analysis. The samples whose probe sets measured present for both arrays but only in one of the two sample types would be considered present and unique for a particular sample type (e.g., pericycle-unique or 3 dpi incompatible syncytia-unique) ([Figure 5](#fig5){ref-type="fig"}). Probe sets that measure detectable amounts of gene activity in both sample types can either be differentially expressed or not differentially expressed ([Figure 6](#fig6){ref-type="fig"}). The differential expression calls used in some of the comparative analyses had been presented previously \[[@B56]\]. The DCM analysis presented here is employed as a different way of examining the data with the goal of identifying genes at low thresholds of expression that are missed in differential expression analyses. More importantly, DCM is also a way of identifying genes that may be expressed at high thresholds in one sample type and are undetectable in a second sample type used for comparative purposes in a differential expression analysis. In cases like these, statistical analyses cannot be done because no expression data is available for the second sample type and thus the probe set is excluded from the differential expression analysis. Therefore, probe sets that measured detectable amounts of a transcript uniquely in one sample type (e.g., unique-present) ([Figure 5](#fig5){ref-type="fig"}) cannot measure differential expression ([Figure 6](#fig6){ref-type="fig"}). An example of genes identified in a comparative analysis of two hypothetical gene pools ([Figure 7](#fig7){ref-type="fig"}) illustrates the different gene categories investigated in the analysis ([Figure 8](#fig8){ref-type="fig"}). As illustrated, all genes that are identified as differentially expressed had to be present in each gene pool ([Figure 7](#fig7){ref-type="fig"}). It became clear from the analysis that many genes that were unique to a specific sample type (e.g., A or B) were being excluded from the differential expression analysis because the probe sets measured detectable levels of gene activity only in one of the two sample types ([Figure 7](#fig7){ref-type="fig"}). The probe sets that match this criterion, A or B and not A U B, became the focus of the analysis ([Figure 8](#fig8){ref-type="fig"}).

3.3. The DCM Identifies Many Genes Expressed in the Experimental Cell Types {#sec3.3}
---------------------------------------------------------------------------

The DCM identified a total of 13,291 transcripts as being present between the pericycle, 3 dpi incompatible syncytium, 3 dpi compatible syncytium, and the 8 dpi compatible syncytium samples. Direct comparisons were made between each of the sample types. The analyses focused on two types of transcripts that were determined to be present. The transcript types are (1) unique and (2) common. Unique transcripts were defined as those that were present and found in only one of the two sample types being compared. Common transcripts were defined as those that were present and overlap between the two sample types being compared. Data from five of the comparisons (Figures [8(a)](#fig8){ref-type="fig"}, [8(c)](#fig8){ref-type="fig"}, [8(e)](#fig8){ref-type="fig"}, [8(g)](#fig8){ref-type="fig"}, [8(i)](#fig8){ref-type="fig"}) are presented as Venn diagrams. The annotated probe sets were divided into seven subcategories (histograms) per functional category (Figures [8(b)](#fig8){ref-type="fig"}, [8(d)](#fig8){ref-type="fig"}, [8(f)](#fig8){ref-type="fig"}, [8(h)](#fig8){ref-type="fig"}, [8(j)](#fig8){ref-type="fig"}(A--R---see figure legends)), based on the particular comparison being made (see below). The comparison in [Figure 8(g)](#fig8){ref-type="fig"}, presented as a Venn diagram, was divided into eight subcategories (histograms) per functional category (see below).

3.4. 3 dpi Syncytia Undergoing an Incompatible Reaction {#sec3.4}
-------------------------------------------------------

The DCM was used to compare present transcripts (genes) within the 3 dpi microdissected syncytia undergoing an incompatible reaction to the pericycle sample (Figures [8(a)](#fig8){ref-type="fig"}and [8(b)](#fig8){ref-type="fig"}). A total of 3,908 genes were present in these two samples. The DCM identified 1,966 genes that were present and unique to the pericycle sample (Figures [8(a)](#fig8){ref-type="fig"}(see Table 1 in Supplementary Material available online at 10.1155/2010/491217)). Further analysis identified 1,002 genes that were present and common between the pericycle and 3 dpi incompatible syncytium sample ([Figure 8(a)](#fig8){ref-type="fig"}(supplementary Table 2)). Only the genes that are present and common can be used for differential expression analyses because expression data was available for each sample type. An analysis identified 940 genes present and unique to the 3 dpi incompatible syncytium sample ([Figure 8(a)](#fig8){ref-type="fig"}(supplementary Table 3)). Therefore, in the analysis presented here, a total of 1,942 genes within 3 dpi incompatible syncytial cell samples were present. Customized computer scripts were written to make seven comparisons of those genes. Some of these comparisons were made to genes identified previously as being differentially expressed between the two cell types under investigation \[[@B56]\]. A histogram of the functional categorizations of the 940 genes present and unique to the 3 dpi incompatible syncytium sample is presented ([Figure 8(b)](#fig8){ref-type="fig"}). Selected gene lists comprising the (1) Disease and Defense, (2) Signaling, and (3) Transcription categories are provided ([Table 1](#tab1){ref-type="table"}(supplementary Table 3)).

3.5. 3 dpi Syncytia Undergoing a Compatible Reaction {#sec3.5}
----------------------------------------------------

The DCM was used to compare genes within the 3 dpi microdissected syncytia undergoing a compatible reaction to the pericycle sample (Figures [8(c)](#fig8){ref-type="fig"}and [8(d)](#fig8){ref-type="fig"}). A total of 4,925 genes were present in these two samples. From these analyses, 711 genes were identified that were present and unique to the pericycle sample ([Figure 8(c)](#fig8){ref-type="fig"}(supplementary Table 4)). Further analysis identified 2,257 genes that were present and common between the pericycle and 3 dpi compatible syncytium sample ([Figure 8(c)](#fig8){ref-type="fig"}(supplementary Table 5)). Only these genes could be used for differential expression analyses because expression data was available for each sample type. The detection call analysis identified 1,957 genes present and unique to the 3 dpi compatible syncytium sample ([Figure 8](#fig8){ref-type="fig"}(supplementary Table 6)). Therefore, in the analysis presented here, a total of 4,214 genes were present within 3 dpi compatible syncytial cell samples. A histogram of the functional categorizations of the 1957 genes present and unique to the 3 dpi compatible syncytium sample described in this section is presented ([Figure 8(d)](#fig8){ref-type="fig"}). Selected gene lists comprising the (1) Disease and Defense, (2) Signaling, and (3) Transcription categories are provided ([Table 2](#tab2){ref-type="table"}(supplementary Table 6)).

3.6. 8 dpi Syncytia Undergoing a Compatible Reaction {#sec3.6}
----------------------------------------------------

The DCM was used to compare genes within the 8 dpi microdissected syncytia undergoing a compatible reaction to the pericycle sample (Figures [8(e)](#fig8){ref-type="fig"}and [8(f)](#fig8){ref-type="fig"}). A total of 4,823 genes were present in these two samples. From these analyses, 656 genes that were present and unique to the pericycle sample were identified ([Figure 8(e)](#fig8){ref-type="fig"}(supplementary Table 7)). Further analysis identified 2,312 genes that were present and common between the pericycle and 8 dpi compatible syncytium sample ([Figure 8(e)](#fig8){ref-type="fig"}(supplementary Table 8)). Only these genes could be used for differential expression analyses because expression data was available for each sample type. The detection call analysis identified 1,855 genes present and unique to the 8 dpi compatible syncytium sample ([Figure 8(e)](#fig8){ref-type="fig"}(supplementary Table 9)). Therefore, in the analysis presented here, a total of 4,167 genes within 8 dpi compatible syncytial cell samples were present. A histogram of the functional categorizations of the 4,167 genes present and unique to the 8 dpi compatible syncytium sample described in this section is presented ([Figure 8(f)](#fig8){ref-type="fig"}). Selected gene lists comprising the (1) Disease and Defense, (2) Signaling, and (3) Transcription categories are provided ([Table 3](#tab3){ref-type="table"}(supplementary Table 9)).

3.7. Direct Comparison: 3 dpi Incompatible versus 3 dpi Compatible Syncytia {#sec3.7}
---------------------------------------------------------------------------

The DCM was used to compare genes within the 3 dpi microdissected syncytia undergoing an incompatible reaction directly to the 3 dpi syncytia undergoing a compatible reaction (Figures [8(g)](#fig8){ref-type="fig"}and [8(h)](#fig8){ref-type="fig"}). A total of 4,793 genes were present in these two samples. From these analyses, 2,851 genes were identified that were present and unique to the 3 dpi compatible syncytium sample ([Figure 8(g)](#fig8){ref-type="fig"}(supplementary Table 10)). Further analysis identified 1,363 genes that were present and common between the 3 dpi syncytia undergoing compatible and incompatible reactions ([Figure 8(g)](#fig8){ref-type="fig"}(supplementary Table 11)). Only these genes could be used for differential expression analyses because expression data was available for each sample type. The detection call analysis identified 579 genes present and unique to the 3 dpi incompatible syncytium sample ([Figure 8(g)](#fig8){ref-type="fig"}(supplementary Table 12)). A histogram of the functional categorizations of the 579 genes present and unique to the 3 dpi incompatible syncytium (as directly compared to the present and unique to the 3 dpi compatible syncytium sample genes) described in this section is presented ([Figure 8(h)](#fig8){ref-type="fig"}). Selected gene lists for the incompatible syncytium ([Table 4](#tab4){ref-type="table"}) and compatible syncytium ([Table 5](#tab5){ref-type="table"}) comprising the (1) Disease and Defense, (2) Signaling, and (3) Transcription categories are provided.

3.8. Direct Comparison: 8 dpi Compatible versus 3 dpi Compatible Syncytia {#sec3.8}
-------------------------------------------------------------------------

The DCM was used to compare genes within the 8 dpi microdissected syncytia undergoing a compatible reaction to the 3 dpi syncytia undergoing a compatible reaction (Figures [8(i)](#fig8){ref-type="fig"}and [8(j)](#fig8){ref-type="fig"}). A total of 5,475 genes were present in these two samples. From these analyses, 1,308 genes were identified that were present and unique to the 3 dpi compatible syncytium sample ([Figure 8(i)](#fig8){ref-type="fig"}(supplementary Table 13)). The detection call analysis identified 2,906 genes that were present and common between the three and 8 dpi syncytia undergoing compatible reactions ([Figure 8(i)](#fig8){ref-type="fig"}(supplementary Table 14)). Only these genes could be used for differential expression analyses because expression data was available for each sample type. Further analysis identified 1,261 genes present and unique to the 8 dpi compatible syncytium sample ([Figure 8(i)](#fig8){ref-type="fig"}(supplementary Table 15)). A histogram of the functional categorizations of the 1,261 genes present and unique to the 8 dpi compatible syncytium sample (as directly compared to the present and unique to the 3 dpi compatible syncytium sample genes) described in this section is presented ([Figure 8(j)](#fig8){ref-type="fig"}). Selected gene lists comprising the (1) Disease and Defense, (2) Signaling, and (3) Transcription categories are provided ([Table 6](#tab6){ref-type="table"}(supplementary Table 15)).

4. Discussion {#sec4}
=============

Microarray experiments typically rely on differential expression analysis methods to identify differences in relative levels of gene expression. However, it is possible that very large differences in gene activity are present when the analysis involves comparing gene expression within homogeneous populations of cells, especially cells that are at different stages of differentiation or become genomically reprogrammed as a consequence of a pathological infection. In the analysis presented here, the DCM was used as an alternative method to identify genes that are expressed in a particular cell type but not active in another cell type. Importantly, the resulting DCM analysis identified a group of genes that were present uniquely within a sample type. However, those same genes were eliminated by differential expression analyses methods because differential expression analyses require expression data from each sample in the comparison.

The DCM is a statistically sound method based on a four-step procedure. The procedude incorporates (1) removal of saturated probes, (2) calculation of discrimination scores, (3) *P*-value calculation using the Wilcoxon\'s rank test, and (4) making the detection call. The DCM has been used in a variety of analyses to understand gene expression in various experimental systems \[[@B93]--[@B82]\]. The DCM analyses have demonstrated the utility of the method. The DCM takes into consideration only the presence of the transcript as measured by the probe set on the microarray. Thus, DCM can be used as a measurement of the diversity of transcripts within those samples.

In the analysis presented here, DCM identified thousands of genes in the 3 dpi incompatible and compatible syncytium samples, the 8 dpi compatible syncytium samples, and the pericycle samples that were isolated by LCM. The DCM, along with customized computer scripts, was then used to compare the transcripts present in those samples. The method allowed for the identification and comparison of transcripts that were found in those samples. The DCM analyses presented here identified transcripts that are found in the incompatible or compatible syncytium samples that did not meet the criteria in a differential expression analysis \[[@B56]\]. Thus, DCM provided a broader (or different) estimate of the similarities and differences in those samples. In all of the comparisons made, the samples exhibited substantial differences in transcript composition. The DCM demonstrated vast differences in transcripts when directly comparing 3 dpi incompatible to compatible syncytia, even though the anatomy of these cells at that time appears similar \[[@B56]--[@B32], [@B60]\].

Comparisons of detection calls between the pericycle control and syncytia undergoing an incompatible reaction resulted in the identification of a disproportionate number of transcripts in the syncytia undergoing an incompatible reaction belonging to the "No Homology to Known Proteins" category. Conversely, the pericycle control had a disproportionate number of transcripts in the "Metabolism" and "Hypothetical Protein Supported by cDNA" categories ([Figure 8(b)](#fig8){ref-type="fig"}). Detection calls can also be used to determine other features of the cells under study. For example, detection calls can be used to arrive at an estimate of how different (or similar) two cell samples or sample types are from each other. Thus, when examining the development of specialized cell types like the syncytium, certain types of gene activity can be identified and used for comparative purposes by using DCM. For example, rapid elicitation of gene expression can be followed by a return to preinfestation levels during a reaction to a pathogen \[[@B90], [@B100]\]. The DCM may allow for the identification of genes expressed at lower levels that are not identified in a differential expression analysis. The DCM will also identify gene expression that is at a high threshold in one sample and absent in the other. This category of genes would be excluded in a differential expression analysis because no statistics can be performed on probe sets lacking expression data.

In this study, DCM aided in identifying additional genes expressed during nematode infection. In the analyses many genes from (1) Disease and Defense, (2) Signaling, and (3) Transcription categories that were unique to one sample type and thus excluded from a differential expression analysis were focused on because of their obvious importance in a variety of plant defense pathways. The analyses here focus on the incompatible analyses. Recent proteomic work by Afzal et al. \[[@B2]\] provides an additional bank of genes to obtain a broader understanding of *H. glycines* infection of *G. max*. The genes identified in the analysis make reasonable candidates for further functional tests \[[@B59]\].

4.1. DCM Is Used to Compare the 3 dpi Incompatible Syncytium to Pericycle Cells {#sec4.1}
-------------------------------------------------------------------------------

The DCM analyses identified genes that were present only in the incompatible syncytial cell sample as compared to the pericycle sample. The genes included various defense response genes. Some of these were DRRG49-C (CF809336), Pto-interacting-kinase (Pti) (BI970555), BOTRYTIS-INDUCED KINASE 1 (BIK1) (AW311265), and two leucine-rich repeat genes (LRRs) (AW348555, AW317282). LRRs near *rhg1* exist \[[@B116]\]. The DRRG49-C gene is induced during pathogen attack \[[@B16]\]. The Pti-kinase \[[@B115]\] and BIK1 \[[@B106]\] are examples of genes that are induced during a response to pathogenic attack and are involved in important defense responses. The identification of a Pti-like kinase was particularly interesting. In *L. esculentum*, *Pti4* and *Pti5* are induced by the virulent *Pseudomonas syringae*pv.*tomato*, the nonhost pathogenic bacterium *Xanthomonas oryzae* pv. *oryzae* (strain PXO^A^  *avrXa10*), and the nonpathogenic bacterium *Pseudomonas fluorescens* (strain 2--79) \[[@B101]\]. Interestingly, Pti kinases are observed at 3 dpi in both compatible and incompatible reactions. The Pti-kinase identified in the 3 dpi incompatible reaction was most closely related to *Pti1* isolated from tomato \[[@B119]\]. In that analysis, *Pti1* was shown to be phosphorylated by *Pto* and to be involved in the hypersensitive response \[[@B119]\]. The LRR genes have a long history as being important for plant defense \[[@B9], [@B49]\]. The genes also have been shown to confer resistance to parasitic nematodes \[[@B13]--[@B43]\]. Thus, due to the transient nature of expression of some of these genes in other systems, it is not surprising that they were not identified as being differentially expressed in syncytium samples \[[@B56]\].

4.2. DCM Is Used to Compare the 3 dpi Incompatible Syncytium Directly to the 3 dpi Compatible Syncytium {#sec4.2}
-------------------------------------------------------------------------------------------------------

The DCM analyses identified genes that were present only in the 3 dpi incompatible syncytium as compared directly to the 3 dpi compatible syncytium sample (supplementary Table 12). The probe sets included genes like haem peroxidase (AW234624), DRT100 (AI443411), thaumatin (CF807955), defender against cell death-1 (DAD-1) (CA936764), polyphenol oxidase (BE659266), calcium dependent protein kinase (AW350917), constitutive photomorphogenic 9 (COP9) subunit 3 (BI968757), WRKY 52 gene (AW394946), and Nonexpressor of PR genes 1 (NPR1) (AW349633) in syncytia undergoing an incompatible reaction at 3 dpi. Importantly, these comparisons were made directly to syncytia undergoing a compatible reaction at 3 dpi. Haem peroxidase \[[@B117]\], DRT100 \[[@B78], [@B79]\], thaumatin \[[@B107]\], DAD-1 \[[@B97]--[@B22]\], polyphenol oxidase \[[@B19]--[@B108]\], calcium dependent protein kinase \[[@B85], [@B46]\], COP9 subunit 3 \[[@B110], [@B64]\], WRKY \[[@B109]--[@B96]\], and NPR1 \[[@B15]\] all perform important roles in defense and/or stress tolerance. Genes like polyphenol oxidase are known to exhibit intense, but transient expression after wounding \[[@B20]\] while a WRKY homolog (WRKY45) exhibits intense, but transient expression after infection \[[@B96]\]. The identification of genes that are known to experience rapid elicitation of gene expression as a consequence of wounding or infection followed by a rapid decline in expression is consistent with their absence from differential expression analyses. The absence could be due to the chronology of infection and syncytium establishment and maintenance \[[@B30]--[@B83], [@B29], [@B31]--[@B48]\].

4.3. DCM Identifies Genes Involved in Defense in the Syncytia Undergoing an Incompatible Reaction {#sec4.3}
-------------------------------------------------------------------------------------------------

Comparisons of 3 dpi resistant syncytia to 3 dpi susceptible syncytia resulted in the identification of polyphenol oxidase (PPO). PPO, also known as catechol oxidase, is an important protein in the defense response, being responsible for catalyzing the oxidation of *o*-diphenols to *o*-diquinones, thereby having diphenolase activity. In some plants, PPO may also perform the *o*-hydroxylation of monophenols, thereby having monophenolase activity \[[@B105]\]. Cellular components react rapidly to the *o*-quinones, whereby they rapidly polymerize and alkylate cell components. Consequently, tissue becomes brown in coloration because of extensive cross-linking of phenols, proteins, and other cellular constituents \[[@B41]--[@B27]\]. Such morphological changes are observed in *G. max*roots undergoing infection by *H. glycines*. Functional tests of PPO activity on pathogens were made in (*Populus tremula*×  *P. alba*) plants overexpressing a hybrid poplar (*Populus trichocarpa*×  *P. deltoides*) PPO (PtdPPO1) gene \[[@B108]\]. Functional tests demonstrate that PPO-overexpressing transgenic plants produce significantly higher mortality and reduced average weight gain in the forest tent caterpillar (*Malacosoma disstria*) larvae feeding on transgenic plants as compared to control plants \[[@B108]\]. Similar experiments, involving the overexpression of a potato (*Solanum tuberosum* L.) PPO in tomato (*Lycopersicon esculentum*Mill. cv. Money Maker), resulted in transgenic plants expressing 30-fold more PPO transcripts \[[@B120]\]. Quantification of PPO protein functionality showed a 5- to 10-fold increase in PPO activity in the transgenic plants \[[@B120]\]. Consequently, the overexpressing PPO transgenic lines produce 15-fold fewer lesions as well as strong inhibition of bacterial growth \[[@B120]\]. Bacterial population growth counts demonstrate at least a 100-fold reduction of bacterial populations in the infected leaves \[[@B120]\]. Thus, PPO could provide a terminal step in plant defense and may provide a localized resistance reaction to *H. glycines* infection.

WRKY transcription factor homologs, involved directly in plant defense, are also identified in syncytia undergoing a resistant reaction. WRKY transcription factors are important in defense \[[@B109]--[@B87], [@B103], [@B95]\]. Shen et al. \[[@B95]\] demonstrated that WRKY genes are important to the resistance response in the specific cells that contain the signaling proteins that are secreted by the pathogen. Shen et al. \[[@B95]\] demonstrated that this is accomplished through leucine rich repeat receptor-like kinase genes (LRRs) involved in resistance. Many LRRs are essential in gene-for-gene resistant (R) interactions \[[@B49]\]. Shen et al. \[[@B95]\] demonstrated that the signals were transduced through R-genes to WRKY transcription factors, resulting in resistance to the pathogen. Importantly, R genes have been shown to confer resistance to parasitic nematodes \[[@B13], [@B42]\]. WRKY gene expression in the syncytial cells during the resistance response is consistent with their suggested roles in plant defense.

The nonexpressor of PR genes (NPR1) (also known as *nim1*(for noninducible immunity 1) and *sai1*) \[[@B86], [@B94]\] is the regulator of salicylic acid-mediated defense. Mutants of NPR1 block SA signaling in *A. thaliana* \[[@B15], [@B94]--[@B39]\]. In the uninduced state, NPR1 exists in the cytoplasm as an oligomer. The oligomer is formed through intermolecular disulfide bonds \[[@B73]\]. Oligomerization is mediated by S-nitrosylation of NPR1 by S-nitrosoglutathione which occurs at cysteine-156 \[[@B99]\]. During systemic acquired resistance (SAR), NPR1 experiences a thioredoxin-mediated reaction that results in its monomerization \[[@B99]\]. This monomerization is induced by mutations at residues Cys82 and Cys216 that facilitated NPR1 monomer accumulation. It also resulted in constitutive nuclear localization. Importantly, the monomerization promoted NPR1-mediated gene expression in the absence of the pathogen \[[@B99]\]. Experiments in *A. thaliana* using mutants in NPR1 (*npr1-2* and *npr1-3*), impaired in SA signaling, demonstrate an increased susceptibility to the beet cyst nematode *H. schachtii* \[[@B114]\]. Conversely, the *npr1*-suppressor mutation *sni1* shows decreased susceptibility to the nematode \[[@B114]\]. Thus, the highly induced expression of thioredoxin during the resistance responses of *G.max*~\[PI  548402/Peking\]~ is consistent with functional tests involving *npr1-2* and *npr1-3*in *A. thaliana*. Induced levels of NPR1 are not observed in syncytium samples of *G.max*~\[PI  548402/Peking\]~. Thioredoxin has been shown to be involved in this process \[[@B99]\]. Therefore, it is possible that thioredoxin transcription accompanies infection. Thus, thioredoxin could be recruited during the defense response to monomerize NPR1 already present in root tissues to accomplish the resistant reaction.

Calmodulin dependent protein kinases (CDPKs) such as calmodulin kinase II (CaMKII) are proteins reliant on calcium for their proper function. The identification of CaMKII indicates that calcium may be playing important roles in resistance. Calcium performs many interesting cellular roles. Calcium, as a second messenger, encodes information through Ca^+2^ gradients, amplitude, and oscillation frequency \[[@B12]\]. Thus, proteins relying on Ca^+2^ gradients and calmodulin may be important during the establishment of the resistant reaction. CaMKII functions by decoding Ca^+2^ oscillation frequencies \[[@B23]\]. At the cellular level, calmodulin is implicated in successful plant-pathogen interactions by its interaction with CDPKs. For example, the arbuscular mycorrhizal interaction in *Medicago truncatula* requires the CDPK, DMI3 \[[@B63]\]. Other symbioses as well are dependent on CDPKs \[[@B63], [@B72]\]. The expression analyses show that calmodulin may be performing some function analogous to those observed for the arbuscular mycorrhizal interaction in *M. truncatula.*

4.4. Orthogonality of the DCM {#sec4.4}
-----------------------------

The DCM has resulted in the identification of probe sets that measure detectable amounts of gene activity in one cell type (present) while absent in the other cell type (Figures [7](#fig7){ref-type="fig"}and [8](#fig8){ref-type="fig"}). The DCM analysis has also identified genes that were common to the two cell types under investigation. As would be expected, there is orthogonality of the DCM probe set lists as compared to probe set lists obtained by the differential expression analysis method. However, since statistical analyses for differential expression analyses can only happen if statistically significant (e.g., measuring present) amounts of gene activity are present in the two cell types under study (e.g., [A]{.ul} ⋃ [B]{.ul}), many genes are eliminated from differential expression analyses. The elimination of the genes occurs because measureable amounts of gene activity as measured by a particular probe set are not present in one of the two samples under study. The exclusion of genes from differential expression analyses is probably less common and less of a problem when the RNA under study is obtained from a whole organism or whole organs (i.e., roots). The problem would be minimized in analyses of whole organisms or organs because they are composed of heterogeneous cell populations, each having unique gene expression programs. The RNA pools of those individual cell types become homogenized during the RNA extraction procedures. In contrast, LCM purifies cells to near homogeneity. Thus, gene expression of homogeneous samples of one cell type may be very different from gene expression found in their neighboring cells or a cell at an earlier point during its developmental process. As shown here, many genes are excluded from a differential expression analysis of nearly homogeneous populations of pericycle cells as compared to syncytia at various stages of their resistant or susceptible reactions. The genes identified in the DCM analyses that are present, but not differentially expressed, became the focus of the analysis presented here. As shown in the multiple analyses, genes that pertain to important classes of genes involved in various plant defense responses to pathogens have been identified by DCM.

5. Summary {#sec5}
==========

The DCM was used to compare syncytium and pericycle samples isolated by LCM. The comparisons presented here are an alternative method of examining microarray gene expression data and are different from those presented in a differential expression analysis of the syncytium \[[@B56]\]. The DCM comparisons are powerful when considering that the cells under investigation are homogeneous (e.g., syncytia). The power of DCM is that it reveals that nearly homogeneous populations of cells have gene activity that is unique to each type. Importantly, differential expression analyses would miss the uniqueness of gene activity of the various cell types because gene expression data is required from each cell type for the analysis to be performed. Therefore, differential expression analyses actually may be underestimating the uniqueness of gene activity profiles for the different cell types under study. The genes identified here represent an additional and significant pool to take into consideration and explore with regard to the interaction between *G. max* and *H. glycines*. The genes can be investigated in functional analyses to study the interaction between *G. max* and *H. glycines* \[[@B58], [@B57]\]. In the broader sense, DCM should be seriously considered as an analysis tool when comparing homogeneous populations of cells.

Supplementary Material {#supplementary-material-sec}
======================
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Supplemental table 1: The DCM was used to compare present transcripts (genes) within the 3 dpi microdissected syncytia undergoing an incompatible reaction to the pericycle sample (Fig. 8a). A total of 3,908 genes were present in these two samples. The DCM identified 1,966 genes that were present and unique to the pericycle sample (Fig. 8a).

Supplemental table 2: The DCM was used to compare present transcripts (genes) within the 3 dpi microdissected syncytia undergoing an incompatible reaction to the pericycle sample (Fig. 8a). A total of 3,908 genes were present in these two samples. Further analysis identified 1,002 genes that were present and common between the pericycle and 3 dpi incompatible syncytium sample (Fig.8a).

Supplemental table 3: The DCM was used to compare present transcripts (genes) within the 3 dpi microdissected syncytia undergoing an incompatible reaction to the pericycle sample (Fig. 8a). A total of 3,908 genes were present in these two samples. An analysis identified 940 genes present and unique to the 3 dpi incompatible syncytium sample (Fig. 8a).

Supplemental table 4: The DCM was used to compare genes within the 3 dpi microdissected syncytia undergoing a compatible reaction to the pericycle sample (Fig. 8c). A total of 4,925 genes were present in these two samples. From these analyses, 711 genes were identified that were present and unique to the pericycle sample (Fig. 8c).

Supplemental table 5: The DCM was used to compare genes within the 3 dpi microdissected syncytia undergoing a compatible reaction to the pericycle sample (Fig. 8c). A total of 4,925 genes were present in these two samples. Further analysis identified 2,257 genes that were present and common between the pericycle and 3 dpi compatible syncytium sample (Fig. 8c).

Supplemental table 6: The DCM was used to compare genes within the 3 dpi microdissected syncytia undergoing a compatible reaction to the pericycle sample (Fig. 8c). A total of 4,925 genes were present in these two samples. The detection call analysis identified 1,957 genes present and unique to the 3 dpi compatible syncytium sample (Fig. 8c).

Supplemental table 7: The DCM was used to compare genes within the 8 dpi microdissected syncytia undergoing a compatible reaction to the pericycle sample (Fig. 8e). A total of 4,823 genes were present in these two samples. From these analyses, 656 genes that were present and unique to the pericycle sample were identified (Fig. 8e).

Supplemental table 8: The DCM was used to compare genes within the 8 dpi microdissected syncytia undergoing a compatible reaction to the pericycle sample (Fig. 8e). A total of 4,823 genes were present in these two samples. Further analysis identified 2,312 genes that were present and common between the pericycle and 8 dpi compatible syncytium sample (Fig. 8e).

Supplemental table 9: The DCM was used to compare genes within the 8 dpi microdissected syncytia undergoing a compatible reaction to the pericycle sample (Figs. 8e). A total of 4,823 genes were present in these two samples. The detection call analysis identified 1,855 genes present and unique to the 8 dpi compatible syncytium sample (Fig.8e).

Supplemental table 10: The DCM was used to compare genes within the 3 dpi microdissected syncytia undergoing an incompatible reaction directly to the 3 dpi syncytia undergoing a compatible reaction (Fig. 8g). A total of 4,793 genes were present in these two samples. From these analyses, 2,851 genes were identified that were present and unique to the 3 dpi compatible syncytium sample (Fig. 8g).

Supplemental table 11: The DCM was used to compare genes within the 3 dpi microdissected syncytia undergoing an incompatible reaction directly to the 3 dpi syncytia undergoing a compatible reaction (Fig. 8g). Further analysis identified 1,363 genes that were present and common between the 3 dpi syncytia undergoing compatible and incompatible reactions (Fig. 8g).

Supplemental table 12: The DCM was used to compare genes within the 3 dpi microdissected syncytia undergoing an incompatible reaction directly to the 3 dpi syncytia undergoing a compatible reaction (Fig.8g). The detection call analysis identified 579 genes present and unique to the 3 dpi incompatible syncytium sample (Fig. 8g).

Supplemental table 13: The DCM was used to compare genes within the 8 dpi microdissected syncytia undergoing a compatible reaction to the 3 dpi syncytia undergoing a compatible reaction (Fig. 8i). A total of 5,475 genes were present in these two samples. From these analyses, 1,308 genes were identified that were present and unique to the 3 dpi compatible syncytium sample (Fig. 8i).

Supplemental table 14: The DCM was used to compare genes within the 8 dpi microdissected syncytia undergoing a compatible reaction to the 3 dpi syncytia undergoing a compatible reaction (Fig. 8i). The detection call analysis identified 2,906 genes that were present and common between the three and 8 dpi syncytia undergoing compatible reactions (Fig. 8i).

Supplemental table 15: The DCM was used to compare genes within the 8 dpi microdissected syncytia undergoing a compatible reaction to the 3 dpi syncytia undergoing a compatible reaction (Fig. 8i). Further analysis identified 1,261 genes present and unique to the 8 dpi compatible syncytium sample (Fig. 8i).
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EST:

:   Expressed sequence tag

hpi:

:   Hours post inoculation

dpi:

:   Days post inoculation

SCN:

:   Soybean cyst nematode

J2:

:   Second stage juvenile

FS:

:   Farmer\'s solution

PFA:

:   Paraformaldehyde

DEPC:

:   Diethylpyrocarbonate

LCM:

:   Laser capture microdissection

MRS:

:   Moisture replacement system

DCM:

:   Detection call methodology.

![Life cycle of *H. glycines*. Cysts, encasing the eggs, are able to remain dormant in the soil for years. At some point, the eggs hatch. The second-stage juveniles (J2s) migrate toward the root and burrow into it. The infective J2s (i-J2s) then migrate toward the root stele. A stylet emerges from the anterior end of the nematode. The nematode selects a pericycle cell or neighboring root cell, for its feeding site. The i-J2 then presumably releases substances that then cause major changes in the physiology of the root cell. Those root cells (yellow) subsequently fuse with neighboring cells (light blue), producing a common cytoplasm. The repeated cell fusion events produces a syncytium (orange) that contains approximately 200 merged root cells and serves as the *H. glycines* feeding site. After the establishment of the syncytium, male nematodes feed for several days. Feeding proceeds until the end of their J3 stage. Meanwhile, the males become sedentary. Subsequently, the males stop feeding, followed by a molt into vermiform J4 males. The males burrow out of the root in preparation for copulation. In contrast to the males, the females become and remain sedentary after the establishment of their feeding site. The female nematodes then increase in size while undergoing both J3 and J4 molts. The J4s then mature, becoming adult feeding females. Ultimately, the female develops into the cyst that encases the eggs. (a) Cysts (dark red) with eggs (white) hatch. (b) Second-stage juveniles (J2) (gray) hatch and migrate toward the root. (c) The J2 nematodes burrow into the root and migrate toward the root stele (dark gray). (d) Feeding site selection (yellow). (e) i-J2 nematodes molt into J3 and then J4. The female is shown here in red. During this time, the original feeding site (yellow) is incorporating adjacent cells (magenta) via cell wall degradation and fusion events. Meanwhile, the male discontinues feeding at the end of its J3 stage. (f) The male and female J4 nematodes mature into adults. By this time, the feeding site has matured into a syncytium (green) as shown here where the female is actively feeding. The vermiform male (blue) migrates out of the root and subsequently copulates with the female (red). (g) After \~30 days, the female is clearly visible externally because its body emerges from the root tissue. The figure is adapted from Klink et al. \[[@B54]\].](JBB2010-491217.001){#fig1}

![*G.* *m* *a* *x* ~\[PI  548402/Peking\]~ seedlings were inoculated with incompatible or compatible *H. glycines* J2 nematodes. Roots were harvested and prepared for histological observation to confirm the establishment of feeding sites at three and 8 dpi. (a) 3 dpi *G.max*~\[PI  548402/Peking\]~ infected with a compatible nematode, black arrowhead; area encircled in red, syncytial cell. (b) 8 dpi *G.max*~\[PI  548402/Peking\]~ infected with a compatible nematode, black arrowhead; area encircled in red, syncytial cell. (c) 3 dpi *G.max*~\[PI  548402/Peking\]~ infected with an incompatible nematode, black arrowhead; area encircled in red, syncytial cell. (d) 8 dpi *G.max*~\[PI  548402/Peking\]~ infected with an incompatible nematode, black arrowhead; area encircled in red, syncytial cell. Bar = 50 *μ*m.](JBB2010-491217.002){#fig2}

![Microdissection of a syncytial cell. (a) A 3 dpi time point syncytial cell (area encircled in red) prior to microdissection was identified by their proximity to *H. glycines* (white arrow). (b) The same syncytial cell section from (a) after microdissection, microdissected syncytial cell (area between white arrows).](JBB2010-491217.003){#fig3}

![Determination of probe sets to be used in the analysis. Sample 1: the particular sample under investigation (e.g., 3 dpi incompatible syncytia). Array 1: first array analyzed by DCM; Array 2: second array analyzed by DCM for a particular sample type. The word *or* refers to the order that the probe set measures present/marginal/absent on array 1 or array 2.](JBB2010-491217.004){#fig4}

![Diagram of the comparative analysis of DCM between two sample types. The probe sets with like measurements are common. The probe sets with dissimilar measurements are unique.](JBB2010-491217.005){#fig5}

![A diagram of the comparative analysis between the (A) DCM and (B) differential expression analyses \[[@B56]\]. DE: differentially expressed.](JBB2010-491217.006){#fig6}

![Comparative analysis of DCM and differential expression analyses. Pools A and B are different sample types. Analyses have identified genes that are unique to A (yellow), genes that are unique to B (green), and genes common to both pools ([A]{.ul} ⋃ [B]{.ul}). Only genes that are present in both A and B can be used for differential expression analyses. The red circle represents the genes that are present in both pools and are also differentially expressed, measuring induced gene activity. The blue circle represents the genes that are present in both pools that are differentially expressed, measuring suppressed gene activity. The remaining genes (white) are present in both samples (common) but are not differentially expressed.](JBB2010-491217.007){#fig7}

###### 

Detection calls. (a, c, e, g, i) Gene counts per sample. (b, d, f, h, j) Functional categories for the histograms. P: pericycle; I3: incompatible syncytium-3 dpi; C3: compatible syncytium 3 dpi; C8: compatible syncytium-8 dpi; DE: differentially expressed. The functional categories are as follows: A: Cell Growth & Division; B: Cell Structure; C: Disease & Defense; D: Energy; E: Intracellular Traffic; F: Metabolism; G: No Homology to Known Proteins; H: Post-Transcription; I: Protein Destination & Storage; J: Protein Synthesis; K: Secondary Metabolism; L: Signal Transduction; M: Transcription; N: Transporter; O: Transposon; P: Unclassified-Hypothetical Protein NOT Supported by cDNA; Q: Unclassified-Hypothetical Protein Supported by cDNA; R: Unclassified-Protein with Unknown Function. (a) Venn diagram depicting P versus I3. The three portions of the Venn diagram show transcripts for P-present-unique; common-present; I3-present-unique. (b) Functional categorization depicting P versus I3. The seven histograms (per functional category) are P-present-unique; common-present; I3-present-unique. The remaining four transcript identifications represent comparisons between those that measured DE \[[@B56]\] and those that were present: I3-present & DE; I3-DE-induced; I3 dpi-DE-suppressed; I3-present & not DE. (c) Venn diagram depicting P versus C3. The three portions of the Venn diagram show transcripts for P-present-unique; common-present; C3-present-unique. (d) Functional categorization depicting P versus C3. The seven histograms (per functional category) are P-present-unique; common-present; C3-present-unique. The remaining four transcript identifications represent comparisons between those that measured DE \[[@B56]\] and those that were present: C3-present & DE; C3-DE-induced; C3-DE-suppressed; C3-present & not DE. (e) Venn diagram depicting P versus C8. The three portions of the Venn diagram show transcripts for P-present-unique; common-present; C8 present-unique. (f) Functional categorization depicting P versus C8. The seven histograms (per functional category) are P-present-unique; common-present; C8-present-unique. The remaining four transcript identifications represent comparisons between those that measured DE \[[@B56]\] and those that were present: C8-present & DE; C8-DE-induced; C8-DE-suppressed; C8-present & not DE. (g) Venn diagram depicting C3 versus I3. The three portions of the Venn diagram show transcripts for C3-present-unique; common-present; I3-present-unique. (h) Functional categorization depicting C3 versus I3. The eight histograms (per functional category) are C3-present-unique; common-present; I3-present-unique. The remaining five transcript identifications represent comparisons between those that measured DE \[[@B56]\] and those that were present: I3-present & DE; I3-DE-induced; I3-DE-suppressed; I3-present & not DE; C3-present & not DE. (i) Venn diagram depicting C3 versus C8. The three portions of the Venn diagram show transcripts for C3-present-unique; common-present; C8-present-unique. (j) Functional categorization depicting C3 versus C8. The seven histograms (per functional category) are C3-present-unique; common-present; C8-present-unique. The remaining four transcript identifications represent comparisons between those that measured DE \[[@B56]\] and those that were present: C8-present & DE; C8-DE-induced; I3-DE-suppressed; C8-present & not DE.

![](JBB2010-491217.008a)

![](JBB2010-491217.008b)

###### 

Select genes that were unique to the 3 dpi syncytia undergoing an incompatible reaction but that were not differentially expressed as compared to a pericycle control sample ([Figure 8(b)](#fig8){ref-type="fig"}) comprising the Disease and Defense, Signaling, and Transcription categories.

  I-3 dpi                                                 
  -------------------------- ------------ --------------- -------------------------------------------------------------
  Probe set ID               Public ID    Avg *P*-value   Gene
                                                          
  Disease & defense                                       
                                                          
  Gma.4886.2.S1_at           AW234624     0.005201937     haem peroxidase
  GmaAffx.69994.1.S1_at      CD417025     0.017952293     phosphate-responsive protein (phi-1)
  Gma.8449.1.S1_s\_at        AF002258.1   0.019563038     CoA ligase 4
  GmaAffx.14986.1.S1_at      BE657889     0.020669698     phosphate-responsive protein (phi-1)
  GmaAffx.93611.1.S1_s\_at   CF809336     0.034312943     disease resistance response protein (DRRG49-C)
                                                          
  Signal transduction                                     
                                                          
  Gma.1965.1.S1_x\_at        L01432.1     0.005201937     calmodulin (SCaM-3)
  GmaAffx.50980.1.S1_x\_at   BE823095     0.006003594     protein phosphatase 2C (PP2C)
  Gma.11041.1.S1_at          BI970555     0.006660588     Pti1-like kinase-like
  GmaAffx.33721.1.S1_at      BI967195     0.006660588     protein kinase
  Gma.6290.1.S1_at           AW311265     0.007290178     BOTRYTIS-INDUCED KINASE1 (BIK1)
  Gma.13604.1.S1_at          CD401537     0.011411572     protein kinase-like
  Gma.9902.1.A1_at           AW395328     0.011756578     FUSCA 5 MAP kinase kinase (FUS5)
  GmaAffx.56323.1.S1_at      BU764214     0.01212639      protein kinase
  Gma.5162.1.A1_at           BI971156     0.013412317     Curculin-like (mannose-binding) protein kinase
  Gma.4455.3.S1_at           CB063632     0.014076915     PROTEIN KINASE 2B (APK2B)
  GmaAffx.21787.1.A1_at      AW348555     0.015096504     leucine-rich repeat transmembrane protein kinase (CLAVATA1)
  GmaAffx.66511.1.S1_at      AW350917     0.019563038     calcium and calmodulin-dependent protein kinase (ATCDPK1)
  GmaAffx.34312.1.S1_at      AI965735     0.023684433     protein phosphatase 2C (PP2C)
  GmaAffx.64402.1.S1_at      AW317282     0.025399823     leucine-rich repeat
  Gma.4801.1.S1_s\_at        BU548608     0.028086024     protein phosphatase 1 (PP1)
  Gma.11291.1.S1_at          AW351207     0.028086024     inositol 1,3,4-trisphosphate 5/6-kinase
  GmaAffx.73451.1.S1_at      BG046889     0.034312943     CALMODULIN-RELATED PROTEIN 2
                                                          
  Transcription                                           
                                                          
  Gma.7212.1.S1_at           BE658102     0.005553929     SUPPRESSOR OF FRIGIDA4 (SUF4)
  GmaAffx.67609.1.S1_at      BG551013     0.009290923     SAR DNA-binding protein-1
  Gma.4165.1.S1_at           BI969143     0.015813164     homeodomain-related
  Gma.4164.1.S1_at           BI968666     0.016772715     MYB transcription factor (MYB112)
  GmaAffx.1165.1.S1_at       BI425542     0.01738237      jasmonate-responsive promoter element
  Gma.15724.2.S1_at          AW350291     0.018668953     CCR4 associated factor 1-related protein
  Gma.1772.1.S1_at           CD406036     0.020753499     transcription factor IIA (TFIIA)
  GmaAffx.52970.1.S1_at      BU548330     0.021323422     zinc finger (DHHC type) family protein
  Gma.4560.1.S1_at           CD393558     0.022830045     TINY-like
  Gma.12330.2.S1_s\_at       BI972758     0.027055562     pathogenesis-related transcriptional factor
  Gma.6838.1.S1_at           AW349633     0.027055562     NIM1-like protein 1 (NPR-1)
  Gma.13614.1.A1_at          CD402000     0.034312943     zinc finger protein

###### 

Select genes that were unique to the 3 dpi syncytia undergoing a compatible reaction but that were not differentially expressed as compared to a pericycle control sample ([Figure 8(d)](#fig8){ref-type="fig"}) comprising the Disease and Defense, Signaling, and Transcription categories.

  2 C-3 dpi                                               
  -------------------------- ------------ --------------- ---------------------------------------------------------------------
  Probe set ID               Public ID    Avg *P*-value   Gene
                                                          
  Disease & defense                                       
                                                          
  Gma.3749.1.S1_at           CD392491     0.002923594     heat shock protein 70 precursor
  GmaAffx.90134.1.S1_s\_at   CF805859     0.008396837     purple acid phosphatase-like protein
  GmaAffx.78614.1.S1_at      BQ611991     0.008396837     Suppressor-of-White-APricot/surp domain-containing protein
  Gma.13217.1.S1_at          CD391191     0.011756578     wound-responsive protein-related
  GmaAffx.11893.1.A1_at      CD414188     0.01212639      regulator of chromatin condensation-1 (RCC1)
  GmaAffx.91519.1.S1_s\_at   CF807244     0.013412317     double-stranded DNA-binding family protein
  GmaAffx.29692.1.S1_at      AW348396     0.016772715     chitinase (class II)
  GmaAffx.71331.1.S1_at      AW597101     0.018428453     galactosyltransferase family protein
  Gma.6640.1.S1_at           BQ628278     0.022040082     haem peroxidase
  Gma.8022.1.S1_at           BQ628998     0.024040827     epoxide hydrolase
  GmaAffx.24201.1.S1_at      BQ740972     0.025685834     Avr9 elicitor response like protein
  Gma.9638.1.A1_at           CA936403     0.029056963     ADR6
                                                          
  Signal transduction                                     
                                                          
  Gma.3893.1.S1_at           U44850.1     0.002298236     Guanine nucleotide-binding protein subunit beta-like protein (ArcA)
  Gma.3286.1.S1_at           BQ298747     0.003021268     putative presenilin
  GmaAffx.33721.1.S1_at      BI967195     0.003317825     calcium/calmodulin-dependent protein kinase (CDPK)
  Gma.17655.1.S1_at          BE057259     0.003317825     protein phosphatase 2A (PP2A)
  Gma.10697.2.S1_at          AW424151     0.003591192     BRI1-associated receptor kinase 1
  Gma.10649.1.S1_at          BE659256     0.004034485     BRI1-associated receptor kinase 1
  Gma.1965.1.S1_x\_at        L01432.1     0.00603523      calmodulin (SCaM-3)
  GmaAffx.52826.3.S1_at      BF596503     0.00846925      protein phpsphatase 2C (PP2C)
  Gma.7517.1.S1_at           BU548272     0.009290923     U box-containing protein kinase
  GmaAffx.50980.1.S1_s\_at   BE823095     0.010694912     protein phpsphatase 2C (PP2C)
  GmaAffx.57055.1.S1_at      AW203411     0.015413718     mitogen-activated protein kinase
  Gma.16954.2.A1_at          BE822903     0.017813909     phospholipase C
  GmaAffx.85565.1.S1_at      BE611082     0.018428453     calcium-dependent protein kinase 29 (CDPK)
  Gma.7177.2.A1_a\_at        BI425372     0.018428453     MHK kinase
  GmaAffx.35805.2.S1_at      BF324178     0.019563038     MAP3K delta-1 protein kinase-like
  Gma.9902.1.A1_at           AW395328     0.019678474     FUSCA 5 MAP kinase kinase (FUS5)
  Gma.2314.1.S1_at           AW310385     0.019678474     FUS3-COMPLEMENTING GENE 1
  GmaAffx.21787.1.A1_at      AW348555     0.020429855     CLAVATA1 receptor kinase (CLV1)
  GmaAffx.69025.1.S1_at      BM271195     0.020753499     RIO kinase
  GmaAffx.62926.1.S1_at      BE804949     0.020828644     G-protein alpha subunit
  Gma.11015.1.S1_at          CD398110     0.023684433     leucine-rich repeat transmembrane protein
  Gma.3185.2.S1_at           BM890715     0.023684433     leucine-rich repeat transmembrane protein
  GmaAffx.15664.1.S1_at      BE607642     0.024040827     LRR receptor-like protein kinase
  GmaAffx.77602.1.S1_at      BQ627622     0.025399823     protein phosphatase-2c (PP2C)
  Gma.5722.1.S1_at           BU546228     0.029056963     Ste20-related protein kinase
  Gma.8364.1.S1_at           BE659226     0.034312943     putative protein kinase (PK12)
                                                          
  Transcription                                           
                                                          
  Gma.4165.1.S1_at           BI969143     0.005201937     homeodomain-related
  Gma.4205.1.S1_at           AF464906.1   0.005679433     repressor protein
  GmaAffx.50673.1.S1_at      BF425742     0.005679433     No apical meristem (NAM) protein
  GmaAffx.67609.1.S1_at      BG551013     0.007110254     SAR DNA-binding protein-1
  Gma.16172.1.S1_at          CD411627     0.009049965     CONSTANS-like B-box zinc finger
  GmaAffx.52855.1.S1_at      AW308923     0.010397582     transcription initiation factor IIE (TFIIE)
  Gma.3176.1.S1_a\_at        BU549115     0.010649919     transcription factor IIA (TFIIA)
  Gma.2702.2.S1_at           AI855587     0.010649919     no apical meristem (NAM)
  Gma.8298.1.S1_at           CD392694     0.012696314     trithorax 4-nuclear SET-domain containing protein
  Gma.4116.2.S1_at           BM177935     0.014076915     transcription initiation factor IIE, beta subunit (TFIiE beta)
  GmaAffx.85579.1.S1_at      BQ273352     0.014307059     lipoamide dehydrogenase
  GmaAffx.81234.1.A1_at      BE823765     0.014307059     TRF-LIKE 8 (TRFL8)
  GmaAffx.66085.1.S1_at      BQ630399     0.015096504     Basic Helix-Loop-Helix (bHLH)
  Gma.13174.1.S1_s\_at       CD414686     0.016772715     indoleacetic acid-induced protein 1 (IAA13)
  GmaAffx.71523.1.S1_at      BU544012     0.01738237      phospatase 2A inhibitor (NAP1-RELATED PROTEIN 1 \[NRP1\])
  GmaAffx.92212.1.A1_s\_at   CF807937     0.018428453     MYB transcription factor (MYB92)
  Gma.7891.1.S1_at           AW310625     0.020753499     Basic Helix-Loop-Helix (bHLH)
  Gma.3632.1.A1_at           BI316950     0.020828644     zinc finger protein
  Gma.17664.1.S1_at          AW348917     0.020828644     zinc finger (DHHC type) family protein
  Gma.2243.2.S1_s\_at        BE807162     0.022028694     transcription initiation factor IIF beta (TFIIF beta)
  Gma.1270.1.S1_at           CD405147     0.022830045     LIM domain-containing, zinc-binding protein
  Gma.752.1.A1_at            AW432463     0.022830045     Helix-loop-helix DNA-binding
  Gma.5274.1.S1_at           BM178426     0.025399823     transcription factor EIL2
  Gma.7776.1.A1_at           CD399260     0.025685834     ATBRM/CHR2
  GmaAffx.52970.1.S1_at      BU548330     0.027055562     zinc finger (DHHC type) family protein
  Gma.7212.1.S1_at           BE658102     0.027055562     Zinc finger, BED-type predicted
  GmaAffx.91768.1.S1_s\_at   CF807493     0.031457154     WRKY27
  Gma.14100.1.S1_at          CD408988     0.034312943     zinc finger, RING-type
  GmaAffx.11131.1.A1_at      CD395293     0.037684072     CCR4 associated factor 1-related protein
  Gma.4281.1.S1_at           AW156348     0.037684072     WRKY

###### 

Select genes that were unique to the 8 dpi syncytia undergoing a compatible reaction but that were not differentially expressed as compared to a pericycle control sample ([Figure 8(f)](#fig8){ref-type="fig"}) comprising the Disease and Defense, Signaling, and Transcription categories.

  3 C-8 dpi                                               
  -------------------------- ------------ --------------- --------------------------------------------------------------------
  Probe set ID               Public ID    Avg *P*-value   Gene
                                                          
  Disease & defense                                       
                                                          
  GmaAffx.91273.1.S1_s\_at   CF805964     0.002747901     wound-induced protein
  Gma.4305.1.S1_at           AW350687     0.00337326      haem peroxidase
  GmaAffx.90134.1.S1_s\_at   CF805859     0.004659843     purple acid phosphatase-like protein
  Gma.8512.1.S1_at           AF236108.1   0.014307059     purple acid phosphatase-like protein
  Gma.7301.1.S1_at           BM528250     0.019563038     gamma-glutamyl transferase
  GmaAffx.78614.1.S1_at      BQ611991     0.019678474     Suppressor-of-White-APricot splicing regulator
  GmaAffx.59573.1.S1_at      AW350986     0.019951841     purple acid phosphatase-like protein
  GmaAffx.91519.1.S1_s\_at   CF807244     0.027055562     double-stranded DNA-binding protein
  Gma.11154.1.S1_a\_at       AW309927     0.031457154     putative elicitor-responsive gene-3
  GmaAffx.83232.1.S1_at      BE023128     0.037684072     MILDEW RESISTANCE LOCUS O 10 (MLO10)
                                                          
  Signal transduction                                     
                                                          
  Gma.1965.1.S1_x\_at        L01432.1     0.001946244     calmodulin (SCaM-3)
  GmaAffx.90377.1.S1_s\_at   CF806102     0.001946244     PP2A regulatory subunit
  Gma.9902.1.A1_at           AW395328     0.002571602     FUSCA 5 MAP kinase kinase (FUS5)
  Gma.7517.1.S1_at           BU548272     0.002923594     U box-containing protein kinase
  Gma.17655.1.S1_at          BE057259     0.00492857      calcium/calmodulin-dependent protein kinase
  GmaAffx.50980.1.S1_at      BE823095     0.007394226     protein phpsphatase 2C (PP2C)
  Gma.4455.3.S1_at           CB063632     0.009290923     PROTEIN KINASE 2B (APK2B)
  Gma.5188.1.S1_at           AW349454     0.010397582     protein phosphatase type-2C
  Gma.9853.1.A1_at           AW350335     0.010397582     LysM domain-containing receptor-like kinase 7
  Gma.10515.1.S1_at          BM528701     0.011324733     calmodulin-binding receptor-like cytoplasmic kinase 3 (CRCK3)
  Gma.5304.2.S1_at           CD410657     0.01212639      membrane-associated progesterone-binding protein 2 (ATMAPR2)
  Gma.1068.1.S1_at           L19360.1     0.013412317     protein kinase 2
  Gma.4631.1.S1_at           BE824210     0.013412974     MITOGEN-ACTIVATED PROTEIN KINASE 1 (ATMPK1)
  Gma.5722.1.S1_at           BU546228     0.013451556     Ste20-related protein kinase
  Gma.596.1.S1_at            AF228501.1   0.015413718     14-3-3-like protein
  Gma.2222.1.S1_at           CD416168     0.015413718     Inositol monophosphatase
  GmaAffx.82748.1.S1_s\_at   BM085604     0.016427052     protein phosphatase 2C (PP2C)
  GmaAffx.67957.1.S1_at      BG157622     0.016772715     RhoGAP small G protein family protein
  Gma.15250.1.S1_x\_at       AI856228     0.016772715     calmodulin
  Gma.10649.1.S1_at          BE659256     0.016932704     BRI1-associated receptor kinase 1
  Gma.8364.1.S1_at           BE659226     0.016932704     ARABIDOPSIS FUS3-COMPLEMENTING GENE (AFC1)
  Gma.10697.2.S1_at          AW424151     0.01738237      protein phosphatase 2A (PP2A) catalytic subunit
  Gma.9706.1.S1_at           BE657400     0.018668953     protein phosphatase 1 (PP1)
  GmaAffx.65281.1.S1_at      CA819808     0.019563038     transmembrane protein
  Gma.2314.1.S1_at           AW310385     0.022040082     ARABIDOPSIS FUS3-COMPLEMENTING GENE (AFC2)
  Gma.10927.1.S1_at          CD398961     0.023684433     root hair defective 3 (RHD3)
  Gma.2471.1.S1_at           AI938029     0.025399823     FUSCA PROTEIN (FUS6)
  Gma.4629.1.A1_at           CA820195     0.028086024     SGT1
  GmaAffx.78968.2.S1_at      BM188587     0.030941813     cysteine protease
  Gma.1518.2.S1_a\_at        BM524684     0.030941813     cysteine protease
  GmaAffx.19821.1.S1_at      CA782536     0.030941813     protein kinase
  Gma.4536.1.A1_at           BI945486     0.034312943     receptor-like protein kinase
                                                          
  Transcription                                           
                                                          
  GmaAffx.92861.1.S1_s\_at   CF808586     0.002923594     HMG-protein
  Gma.1748.2.S1_a\_at        CA820372     0.003591192     no apical meristem (NAM) protein (NAC1)
  Gma.17736.1.S1_at          AW598570     0.00603523      zinc finger, C2H2-type
  Gma.4165.1.S1_at           BI969143     0.007394226     Homeodomain-related
  Gma.6739.1.S1_s\_at        AI856042     0.007667593     RNA polymerase II (RPB15.9)
  Gma.2844.1.S1_at           BI972378     0.008019584     auxin-induced protein 2
  Gma.2258.2.S1_a\_at        BG237280     0.008396837     pre-mRNA processing ribonucleoprotein (NOP5)
  GmaAffx.54382.1.A1_at      BE807592     0.00846925      calmodulin-binding transcription activator 4
  GmaAffx.50673.1.S1_at      BF425742     0.009049965     no apical meristem (NAM) protein
  GmaAffx.41946.1.S1_at      BM528357     0.009290923     helix-loop-helix DNA-binding
  GmaAffx.78992.1.S1_at      BU760819     0.010397582     HMG-I and HMG-Y DNA-binding protein
  Gma.2465.1.S1_at           CD390577     0.010694912     ARABIDOPSIS THALIANA HOMEOBOX PROTEIN 54 (ATHB54)
  GmaAffx.42667.1.S1_at      BU761164     0.011051366     SCARECROW-LIKE 1 (SCL1)
  GmaAffx.66085.1.S1_at      BQ630399     0.011411572     basic helix-loop-helix (bHLH)
  Gma.4975.1.S1_at           BI970178     0.011756578     zinc finger, CCCH-type; Zinc finger, RING-type
  Gma.6838.1.S1_at           AW349633     0.011756578     NIM1-like protein 1 (NPR-1)
  GmaAffx.91768.1.S1_s\_at   CF807493     0.013412317     WRKY27
  GmaAffx.81622.1.S1_at      BM093159     0.013412317     bZIP transcription factor bZIP123
  Gma.3609.1.S1_at           CD392010     0.013412317     helix-loop-helix DNA-binding
  GmaAffx.85579.1.S1_at      BQ273352     0.014307059     lipoamide dehydrogenase-UNE12 (unfertilized embryo sac 12)
  GmaAffx.60479.4.S1_at      BG507369     0.014307059     BEL1-like homeodomain transcription factor
  GmaAffx.24357.1.A1_at      BU544827     0.014526581     zinc finger (DHHC type) family protein
  Gma.7212.1.S1_at           BE658102     0.016772715     SUPPRESSOR OF FRIGIDA4 (SUF4)
  Gma.3632.1.A1_at           BI316950     0.016772715     zinc finger protein
  Gma.15748.1.A1_at          AI900530     0.017813909     WRKY15
  Gma.16645.1.S1_at          BM143429     0.017952293     no apical meristem (NAM) protein (NAC2)
  Gma.4225.1.S1_a\_at        AW317387     0.018428453     transcription initiation factor IID (TFIID)
  Gma.1772.1.S1_at           CD406036     0.019678474     transcription factor IIA (TFIIA)
  Gma.16172.1.S1_at          CD411627     0.020429855     CONSTANS-like B-box zinc finger
  GmaAffx.65829.1.A1_at      CD392418     0.020669698     pathogenesis-related transcriptional factor and ERF
  Gma.4281.1.S1_at           AW156348     0.020669698     WRKY
  Gma.12798.1.S1_at          CD390501     0.020828644     PHYTOCHROME A SIGNAL TRANSDUCTION 1 (PAT1)
  GmaAffx.85720.1.S1_at      CD415193     0.022040082     basic helix-loop-helix (bHLH)
  GmaAffx.87860.1.S1_at      BU081275     0.023684433     MYB transcription factor
  Gma.11345.1.S1_at          BE024036     0.025230236     MYB transcription factor (MYB92)
  GmaAffx.41422.2.S1_at      BI321807     0.027055562     PHD1
  GmaAffx.552.1.S1_at        BI785020     0.027055562     RNA polymerase dimerisation domain containing protein (Rpb3/Rpb11)
  GmaAffx.37827.1.S1_at      CD414912     0.028086024     gibberellic acid-insensitive mutant protein 1 (GAI1)/DELLA protein
  GmaAffx.73813.1.S1_at      BU551266     0.029056963     Arabidopsis NAC domain containing protein 104 (ANAC104/XND1)
  GmaAffx.67609.1.S1_at      BG551013     0.029056963     SAR DNA-binding protein-1
  GmaAffx.91229.1.S1_s\_at   CF806954     0.030941813     AUXIN RESISTANT 3 (AXR3)
  GmaAffx.1957.1.S1_at       BM271285     0.030941813     WIP1 protein
  Gma.4207.3.S1_a\_at        BE804803     0.031457154     MYB transcription factor (MYB48)

###### 

An analysis compared the 3 dpi syncytia undergoing an incompatible reaction directly to the 3 dpi compatible syncytium samples. Selected genes that were unique to the 3 dpi syncytia undergoing an incompatible reaction but that were not differentially expressed as compared directly to the 3 dpi compatible syncytium samples ([Figure 8(h)](#fig8){ref-type="fig"}) comprising the Disease and Defense, Signaling, and Transcription categories are provided.

  I-3 dpi genes in the comparison of I-3 dpi to C-3 dpi                                
  ------------------------------------------------------- ------------ --------------- -----------------------------------------------------------
  Probe set ID                                            Public ID    Avg *P*-value   Gene
                                                                                       
  Disease & defense                                                                    
                                                                                       
  Gma.4886.2.S1_at                                        AW234624     0.005201937     haem peroxidase
  Gma.405.1.A1_at                                         AI443411     0.008396837     leucine-rich repeat family protein (DRT100)
  Gma.2044.2.S1_at                                        BE821230     0.011411572     abscisic stress ripening-like protein
  GmaAffx.92230.1.A1_s\_at                                CF807955     0.012305657     thaumatin-like protein PR-5b
  Gma.7542.2.S1_at                                        CA936764     0.016772715     defender against cell death 1 (DAD-1)
  Gma.8449.1.S1_s\_at                                     AF002258.1   0.019563038     CoA ligase 4
  GmaAffx.14986.1.S1_at                                   BE657889     0.020669698     PHOSPHATE-INDUCED 1 (phi-1)
  GmaAffx.2203.1.S1_at                                    CD415745     0.020669698     cadmium-induced protein
  GmaAffx.91141.1.S1_at                                   CF806866     0.020828644     peroxidase 1 precursor
  GmaAffx.46214.1.S1_at                                   BE659266     0.022934167     polyphenol oxidase
                                                                                       
  Signal transduction                                                                  
                                                                                       
  Gma.13604.1.S1_at                                       CD401537     0.011411572     protein kinase
  GmaAffx.56323.1.S1_at                                   BU764214     0.01212639      protein kinase
  Gma.6092.1.S1_at                                        BI968757     0.012305657     COP9 signalosome subunit 3
  Gma.5162.1.A1_at                                        BI971156     0.013412317     Curculin-like (mannose-binding) lectin protein kinase
  Gma.4455.3.S1_at                                        CB063632     0.014076915     PROTEIN KINASE 2B (APK2B)
  GmaAffx.66511.1.S1_at                                   AW350917     0.019563038     calcium and calmodulin-dependent protein kinase (ATCDPK1)
  GmaAffx.34312.1.S1_at                                   AI965735     0.023684433     protein phosphatase 2C (PP2C)
  GmaAffx.64402.1.S1_at                                   AW317282     0.025399823     leucine-rich repeat
  Gma.4801.1.S1_s\_at                                     BU548608     0.028086024     protein phosphatase 1 (PP1)
  Gma.11291.1.S1_at                                       AW351207     0.028086024     inositol 1,3,4-trisphosphate 5/6-kinase
  GmaAffx.73451.1.S1_at                                   BG046889     0.034312943     CALMODULIN-RELATED PROTEIN 2
                                                                                       
  Transcription                                                                        
                                                                                       
  GmaAffx.89077.1.A1_s\_at                                CK605647     0.009323331     CONSTANS interacting protein 2a
  Gma.3996.1.S1_at                                        AW394946     0.014307059     WRKY52
  Gma.9678.1.S1_at                                        CD404894     0.016707249     RNA polymerase II
  Gma.12330.2.S1_s\_at                                    BI972758     0.027055562     pathogenesis-related transcriptional factor
  Gma.6838.1.S1_at                                        AW349633     0.027055562     NIM1-like protein 1 (NPR-1)
  Gma.16645.1.S1_at                                       BM143429     0.028086024     Arabidopsis NAC domain-containing protein 1 (ATAF1)

###### 

An analysis compared the 3 dpi syncytia undergoing an incompatible reaction directly to the 3 dpi compatible syncytium samples. Selected genes that were unique to the 3 dpi syncytia undergoing a compatible reaction but that were not differentially expressed as compared directly to the 3 dpi incompatible syncytium samples ([Figure 8(h)](#fig8){ref-type="fig"}) comprising the Disease and Defense, Signaling, and Transcription categories.

  C-3 dpi genes in the comparison of I-3 dpi to C-3 dpi                                
  ------------------------------------------------------- ------------ --------------- ----------------------------------------------------------------
  Probe set ID                                            Public ID    Avg *P*-value   Gene
                                                                                       
  Disease & defense                                                                    
                                                                                       
  GmaAffx.36484.1.S1_s\_at                                BI425441     0.001672877     PR1a
  Gma.6091.1.S1_at                                        AW310762     0.00221961      haem peroxidase
  Gma.2523.1.S1_s\_at                                     CA852440     0.002747901     R 14 protein
  GmaAffx.85114.1.S1_s\_at                                AW760844     0.003021268     Malus major allergen (Mal d 1.07)
  Gma.4312.3.S1_a\_at                                     BF424240     0.003822926     glutathione peroxidase (GSH-PX3)
  Gma.257.2.S1_a\_at                                      CD400364     0.005553929     cysteine proteinase inhibitor
  GmaAffx.36514.1.S1_at                                   BE658341     0.005553929     cationic peroxidase
  Gma.6299.3.S1_at                                        BU547701     0.00603523      selenium binding protein
  GmaAffx.92699.1.S1_s\_at                                CF808424     0.006308596     PR-5 protein
  Gma.5141.1.S1_at                                        BI971102     0.007667593     laccase 3 (LAC3)
  Gma.9504.1.S1_at                                        CA803130     0.007680178     plant disease resistance response protein
  Gma.18084.1.S1_at                                       BI317557     0.008396837     RESPIRATORY BURST OXIDASE HOMOLOG (ATRBOHB)
  Gma.8144.1.A1_at                                        BU548599     0.009323331     cationic peroxidase
  GmaAffx.11893.1.A1_at                                   CD414188     0.01212639      regulator of chromatin condensation-1 (RCC1)
  Gma.4077.1.S1_at                                        CD414118     0.012696314     ASR protein
  Gma.7257.2.S1_at                                        BG155489     0.016427052     soluble epoxide hydrolase
  GmaAffx.71331.1.S1_at                                   AW597101     0.018428453     galactosyltransferase family protein
  GmaAffx.52146.1.S1_at                                   CA934966     0.028086024     PATHOGENESIS-RELATED 4 (PR4)
  Gma.9638.1.A1_at                                        CA936403     0.029056963     ADR6
                                                                                       
  Signal transduction                                                                  
                                                                                       
  GmaAffx.92136.1.S1_s\_at                                CF807451     0.001672877     Curculin-like (mannose-binding) lectin protein kinase
  Gma.6338.1.S1_at                                        AI442775     0.001946244     protein phosphatase 2C (PP2C)
  Gma.3893.1.S1_at                                        U44850.1     0.002298236     Arabidopsis thaliana Homolog of the Tobacco ArcA (ATARCA)
  Gma.4228.1.S1_at                                        AI856764     0.002298236     RelA-SpoT like protein (RSH3)
  Gma.13033.1.A1_a\_at                                    CD392795     0.002298236     calcium-dependent calmodulin-independent protein kinase (CDPK)
  Gma.6709.1.S1_at                                        BE823291     0.002747901     CBL-interacting protein kinase 22
  Gma.10697.2.S1_at                                       AW424151     0.003591192     protein phosphatase 2A catalytic subunit
  Gma.11006.1.S1_s\_at                                    AW706204     0.00492857      CBL-interacting protein kinase
  Gma.6359.1.S1_at                                        CD398481     0.005201937     caltractin-like
  GmaAffx.92229.1.S1_s\_at                                CF806381     0.005553929     14-3-3 protein
  Gma.4507.1.S1_at                                        BG653255     0.006308596     leucine-rich repeat protein
  Gma.568.1.S1_at                                         BI967984     0.007110254     LRR receptor-like protein kinase
  GmaAffx.90655.1.S1_s\_at                                CF806380     0.007680178     14-3-3-like protein C (SGF14C)
  GmaAffx.91570.1.A1_s\_at                                CF807732     0.008019584     JUN-activation-domain-binding protein
  Gma.4049.1.S1_at                                        BQ786519     0.008184263     wall-associated kinase (WAK-like kinase)
  Gma.3083.1.S1_at                                        BE474466     0.008396837     BAK1 (BRI1-ASSOCIATED RECEPTOR KINASE)
  Gma.7517.1.S1_at                                        BU548272     0.009290923     protein kinase
  GmaAffx.25928.1.S1_at                                   CD414013     0.012305657     WD-40 repeat protein
  Gma.15907.1.A1_at                                       CD407154     0.014307059     leucine-rich repeat protein
  Gma.3852.1.S1_at                                        CD399104     0.014771313     serine/threonine-protein phosphatase PP1
  GmaAffx.57055.1.S1_at                                   AW203411     0.015413718     Arabidopsis thaliana MAP kinase 2 (ATMPK20)
  Gma.10215.1.S1_a\_at                                    AY263347.1   0.016307345     Pti1-like kinase
  GmaAffx.85565.1.S1_at                                   BE611082     0.018428453     calcium-dependent protein kinase 29 (CPK29)
  Gma.7177.2.A1_a\_at                                     BI425372     0.018428453     Cdc2-related protein kinase (CRK2)
  GmaAffx.35805.2.S1_at                                   BF324178     0.019563038     MAP3K delta-1 protein kinase-like
  Gma.10798.1.S1_at                                       CD401168     0.019563038     protein phosphatase 2A (PP2A)
  Gma.2314.1.S1_at                                        AW310385     0.019678474     ARABIDOPSIS FUS3-COMPLEMENTING GENE (AFC2)
  Gma.1517.2.S1_a\_at                                     BE059859     0.019951841     calcium dependent calmodulin independent protein kinase (CDPK)
  Gma.6123.1.S1_at                                        AW349800     0.020669698     VERNALIZATION INDEPENDENCE 3 (VIP3)
  GmaAffx.69025.1.S1_at                                   BM271195     0.020753499     RIO kinase
  GmaAffx.62926.1.S1_at                                   BE804949     0.020828644     extra-large GTP-binding protein 3 (XLG3)
  GmaAffx.40750.1.S1_s\_at                                BG352469     0.022028694     protein phosphatase 2A regulatory subunit (PP2A)
  GmaAffx.44305.1.S1_at                                   BU551393     0.022830045     transmembrane protein
  Gma.3185.2.S1_at                                        BM890715     0.023684433     leucine-rich repeat transmembrane protein
  Gma.11015.1.S1_at                                       CD398110     0.023684433     leucine-rich repeat transmembrane protein
  GmaAffx.15664.1.S1_at                                   BE607642     0.024040827     leucine-rich repeat transmembrane protein
  Gma.1423.1.S1_s\_at                                     AI960045     0.024040827     BRASSINAZOLE-RESISTANT 1 (BZR1)
  Gma.4044.1.S1_at                                        BE821233     0.025399823     Pescadillo-like
  GmaAffx.89525.1.S1_s\_at                                CK606517     0.027055562     protein phosphatase 1 (PP1)
  Gma.7387.1.A1_a\_at                                     CD396910     0.027055562     pseudo-response regulator
  Gma.5722.1.S1_at                                        BU546228     0.029056963     Ste20-related protein kinase
  Transcription                                                                        
                                                                                       
  Gma.1538.1.S1_a\_at                                     AW351115     0.002298236     salt tolerance protein 6
  Gma.12279.1.A1_at                                       CD397826     0.00337326      basic helix-loop-helix (bHLH)
  Gma.5331.1.S1_at                                        BI892702     0.004307852     no apical meristem (NAM) protein NAC4
  Gma.593.2.S1_x\_at                                      CA800286     0.00492857      MYB transcription factor (MYB173)
  GmaAffx.5069.2.A1_at                                    BM121565     0.005201937     basic-leucine zipper (bZIP111)
  GmaAffx.50673.1.S1~-~at                                 BF425742     0.005679433     no apical meristem (NAM) protein (NAC)
  GmaAffx.93436.1.A1~-~s~-~at                             CF809161     0.007680178     AP2/EREBP transcription factor ERF-2
  GmaAffx.38951.1.S1_at                                   BI322098     0.008396837     basic-leucine zipper (bZIP)
  Gma.16172.1.S1_at                                       CD411627     0.009049965     CONSTANS-LIKE 13
  Gma.3730.2.S1_a\_at                                     BI320846     0.009290923     WRKY27
  Gma.15862.1.S1_at                                       BI970593     0.009323331     pathogenesis-related transcriptional factor and ERF
  Gma.2702.2.S1_at                                        AI855587     0.010649919     no apical meristem (NAM) protein
  Gma.163.1.S1_at                                         AB029269.1   0.014076915     MYB transcription factor (MYB12)
  Gma.16613.1.S1_s\_at                                    BU760651     0.014307059     zinc finger
  GmaAffx.81234.1.A1_at                                   BE823765     0.014307059     MYB-TRFL8 (TRF-LIKE 8)
  GmaAffx.15471.1.S1_at                                   BQ611747     0.014526581     MYB transcription factor (MYB139)
  Gma.17432.1.S1_s\_at                                    AW277783     0.015813164     RNA polymerase subunit (RPB5)
  Gma.13174.1.S1_s\_at                                    CD414686     0.016772715     aux/IAA protein (IAA13)
  GmaAffx.71523.1.S1_at                                   BU544012     0.01738237      Polycomb group-NAP1-RELATED PROTEIN 1 (NRP1)
  Gma.15460.1.S1_at                                       CD403496     0.018032044     ethylene-induced calmodulin binding protein (EICBP.B)
  GmaAffx.92212.1.A1_s\_at                                CF807937     0.018428453     MYB transcription factor (MYB92)
  Gma.5483.1.S1_s\_at                                     CD414581     0.019563038     basic-leucine zipper (bZIP105)
  Gma.7891.1.S1_at                                        AW310625     0.020753499     basic helix-loop-helix
  Gma.3632.1.A1_at                                        BI316950     0.020828644     zinc finger protein
  Gma.17664.1.S1_at                                       AW348917     0.020828644     zinc finger (DHHC type) family protein
  Gma.752.1.A1_at                                         AW432463     0.022830045     helix-loop-helix DNA-binding
  Gma.7341.1.A1_s\_at                                     CA953350     0.022830045     aux/IAA protein (IAA3)
  GmaAffx.44143.1.S1_at                                   BU547730     0.023684433     CCR4-Not complex component (Not1)
  GmaAffx.50295.1.S1_at                                   BI424123     0.024040827     zinc finger (C2H2 type, AN1-like)
  GmaAffx.76537.1.S1_at                                   CD416417     0.025399823     MYC1
  Gma.5274.1.S1_at                                        BM178426     0.025399823     transcription factor EIL2
  GmaAffx.91768.1.S1_s\_at                                CF807493     0.031457154     WRKY27
  Gma.6571.2.S1_a\_at                                     BE191621     0.031457154     transcription initiation factor IIA (TFIIA)
  Gma.4281.1.S1_at                                        AW156348     0.037684072     WRKY
  Gma.15184.1.S1_at                                       BM522992     0.037684072     homeobox-leucine zipper protein 22 (HAT22)

###### 

Select genes that were unique to the 8 dpi syncytia undergoing a compatible reaction but that were not differentially expressed as compared directly to the 3 dpi compatible syncytium samples ([Figure 8(j)](#fig8){ref-type="fig"}) comprising the Disease and Defense, Signaling, and Transcription categories.

  C-8 dpi as compared to C-3 dpi                                
  -------------------------------- ------------ --------------- --------------------------------------------------------------
  Probe set ID                     Public ID    Avg *P*-value   Gene
                                                                
  Disease & defense                                             
                                                                
  GmaAffx.8704.2.S1_at             BG042982     0.003021268     Peroxidase
  Gma.8512.1.S1_at                 AF236108.1   0.014307059     purple acid phosphatase
  GmaAffx.93342.1.S1_s\_at         CF809067     0.014526581     glutathione peroxidase 1
  Gma.7301.1.S1_at                 BM528250     0.019563038     GAMMA-GLUTAMYL TRANSPEPTIDASE 3 (GGT3)
  GmaAffx.59573.1.S1_at            AW350986     0.019951841     purple acid phosphatase
  Gma.13182.1.S1_at                CD392298     0.020669698     copper-binding protein (CUTA)
  Gma.320.1.S1_at                  AF019116.1   0.024040827     Peroxidase
  Gma.11154.1.S1_a\_at             AW309927     0.031457154     elicitor-responsive gene
                                                                
  Signal transduction                                           
                                                                
  GmaAffx.21217.3.S1_at            AW569872     0.004392849     protein phosphatase 2C (PP2C)
  Gma.4455.3.S1_at                 CB063632     0.009290923     PROTEIN KINASE 2B (APK2B)
  Gma.2407.1.S1_at                 BI970419     0.009755834     putative protein kinase
  Gma.5304.2.S1_at                 CD410657     0.01212639      membrane-associated progesterone-binding protein 2 (ATMAPR2)
  Gma.1007.1.S1_a\_at              CD402215     0.015096504     calmodulin-related protein
  Gma.2222.1.S1_at                 CD416168     0.015413718     inositol monophosphatase
  Gma.596.1.S1_at                  AF228501.1   0.015413718     14-3-3-like protein
  GmaAffx.67957.1.S1_at            BG157622     0.016772715     RhoGAP small G protein family protein
  GmaAffx.73932.1.S1_s\_at         BU550426     0.017952293     CTR1-like protein kinase
  Gma.4487.2.S1_at                 AW508329     0.020753499     calcium ion binding
  GmaAffx.91867.1.S1_x\_at         CF807592     0.028086024     14-3-3 protein
  Gma.4629.1.A1_at                 CA820195     0.028086024     SGT1
  Gma.1518.2.S1_a\_at              BM524684     0.030941813     cysteine protease
  GmaAffx.19821.1.S1_at            CA782536     0.030941813     serine/threonine protein kinase
                                                                
  Transcription                                                 
                                                                
  GmaAffx.92861.1.S1_s\_at         CF808586     0.002923594     HIGH MOBILITY GROUP B 1 (HMGB1)
  Gma.3419.2.S1_at                 BE658641     0.005201937     zinc finger, C2H2-type
  Gma.6739.1.S1_s\_at              AI856042     0.007667593     RNA polymerase II 15.9 (RPB15.9)
  GmaAffx.41946.1.S1_at            BM528357     0.009290923     helix-loop-helix DNA-binding
  GmaAffx.42667.1.S1_at            BU761164     0.011051366     SCARECROW-LIKE 1 (SCL1)
  Gma.6476.2.S1_x\_at              BQ453135     0.011324733     polynucleotidyl transferase
  GmaAffx.30434.1.S1_at            BQ081227     0.011676724     helix-loop-helix DNA-binding
  Gma.4975.1.S1_at                 BI970178     0.011756578     zinc finger, CCCH-type- RING-type
  Gma.6838.1.S1_at                 AW349633     0.011756578     NIM1-like protein 1 (NPR-1)
  GmaAffx.58899.1.S1_at            BI317760     0.016307345     C2-H2 zinc finger protein
  Gma.16645.1.S1_at                BM143429     0.017952293     no apical meristem (NAM) protein (NAC2)
  GmaAffx.65829.1.A1_at            CD392418     0.020669698     pathogenesis-related transcriptional factor and ERF
  GmaAffx.53755.1.S1_at            BQ454195     0.022028694     BEL-like homeodomain protein 3
  GmaAffx.73306.1.S1_at            BE658301     0.022040082     single-stranded nucleic acid binding R3H
  GmaAffx.87860.1.S1_at            BU081275     0.023684433     MYB transcription factor
  Gma.11345.1.S1_at                BE024036     0.025230236     MYB transcription factor (MYB92)
  GmaAffx.90313.1.S1_s\_at         CF806038     0.025685834     no apical meristem (NAM) protein NAC5
  GmaAffx.73813.1.S1_at            BU551266     0.029056963     Arabidopsis NAC domain containing protein 104 (ANAC104/XND1)
  GmaAffx.1957.1.S1_at             BM271285     0.030941813     WIP1 protein
  Gma.8118.1.A1_at                 BE819846     0.031457154     zinc finger, C3HC4-type RING finger

[^1]: Academic Editor: Tanya Parish
